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ABSTRACT
The 7-deazaguanosine nucleosides queuosine (Q) and archaeosine (G+) are two
of the most structurally complex modified nucleosides found in tRNA. Q is found
exclusively in the wobble position of tRNAGUN coding for the amino acids asparagine,
aspartate, histidine and tyrosine in eukarya and bacteria, while G+ occurs in nearly all
archaeal tRNA at position 15.
In archaea preQ0 is inserted into tRNA by the enzyme tRNA-guanine
transglycosylase (TGT), which catalyzes the exchange of guanine with preQ0 to
produce preQ0-tRNA. The first objective of this study was to identify and characterize
the enzyme(s) catalyzing the conversion of preQ0-tRNA to G+-tRNA. Comparative
genomics identified a protein family possibly involved in the final steps of archaeosine
biosynthesis, which was annotated as TgtA2. Structure based alignments comparing
TGT and TgtA2 revealed that TgtA2 lacked key TGT catalytic residues and contained
an additional module. The gene corresponding to tgtA2 from Methanocaldococcus
jannaschii (mj1022) was cloned, expressed and the purified recombinant enzyme
characterized. Recombinant MjTgtA2 was shown to convert preQ0-tRNA to G+-tRNA
using glutamine, asparagine or NH4+ as nitrogen donors in an ATP-independent
reaction. This is the only example of the conversion of a nitrile to a formamidine
known in biology.
QueF catalyzes the reduction of preQ0 to 7-aminomethyl-7-deazaguanine
(preQ1) in the queuosine biosynthetic pathway. The second aim of this study was the
transient state kinetic analysis of substrate binding and catalysis by the enzyme QueF,
i

as well as investigation of the effects of ligands on its quaternary structure. Gel
filtration and sedimentation equilibrium analyses indicated that QueF exists as a
hybrid population in a rapid equilibrium between decamer and pentamer states.
Addition of preQ0 to QueF resulted in shifting the equilibrium towards the decamer
state, as did the addition of divalent metals. Potassium chloride at high concentrations
was found to disrupt the quaternary structure of QueF.

Intrinsic tryptophan and

NADPH fluorescence was used to determine the substrate binding to QueF by
stopped-flow kinetic studies. Studies on the binding of preQ0 to QueF in conjuction
with binding NADPH to the QueF mutant E78A-thioimide intermediate suggested a
two-step mechanism consisting of a fast bimolecular process and a subsequent slower
unimolecular process, while the binding of preQ0 to the C55A mutant was
monophasic, consisting of only the fast bimolecular process. Thioimide formation
was monitored by UV-Vis; under single turnover conditions the data fit well to single
exponential rise.
observed.

However, at high preQ0 concentrations two phases could be

The reduction of the thioimide was determined under single turnover

conditions by both UV-Vis and fluorescence, and comparable rates were obtained
from both techniques. These results indicate that the binding of preQ0 and NADPH to
QueF, as well as thioimide formation, are very rapid; and that reduction of the
thioimide is most likely the rate limiting step. Analysis of component rates suggests
structural changes occur between these steps, further limiting the overall rate.
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1. INTRODUCTION
1.1 Transfer ribonucleic acids
Structure and function
Transfer ribonucleic acid (tRNA) is the information adapter molecule interfacing the
amino-acid sequence of a protein and the genetic information in deoxyribonucleic acid
(DNA). The function of tRNA is essential to the process of translation, engaging in
highly specific interactions with both nucleic acids and proteins. Most tRNAs from all
organisms have a similar cloverleaf-fold secondary structure. Typically, there are four
arms and three loops: the acceptor, D (dihydrouridine), TΨC (T-pseudouridine-C) and
anticodon arms, D, TΨC and anticodon loops (some tRNA molecules feature a fourth or
variable loop). The tertiary L-shape of tRNA is the result of the stacking of the acceptor
arm onto the TΨC arm and of the D arm onto the anticodon arm yielding the acceptor
stem and anticodon stem respectively (1). Most tRNAs have between 75-95 nucleotides.

In addition to the role of tRNA in protein synthesis, tRNA is also involved in a variety of
other functions, including the activation of amino acids, initiation and regulation of
protein synthesis, RNA metabolism, nuclease degradation, reverse transcriptase primer,
cell wall biosynthesis, membrane components and protein modification (2).
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Modification of nucleoside bases

A characteristic structural feature of RNA is the presence of post-transcriptional
modifications, with naturally occurring RNAs containing numerous chemically altered
nucleosides. They are formed by enzymatic modification of the primary transcripts
during the complex RNA maturation process.

To date, over 100 structurally

distinguishable modified nucleosides originating from different types of RNAs have been
reported and collected in the RNA Modification Database (3, 4). The extent of total
nucleoside modification in tRNA molecules from plant and mammals is high (up to
25%), whereas that in homologous tRNAs from bacteria is lower (2-15%) and the
organelles have the lowest level of modification (1-6%) (5).

The modifications of the four canonical nucleosides adenosine, guanosine, uridine and
cytosine vary from simple structural changes of the base or ribosyl moieties to hypermodifications (1). Simple modifications typically require a single enzyme and involve a
small structural change such as methylation, isomerization or reduction of a base (1),
whereas hyper-modification of nucleosides typically involves multiple enzymatic steps
and results in substantial structural changes (1). Very few enzymes are needed for the
transcription of tRNA, whereas a vast number participate in its post-transcriptional
modification. An estimated 1% of bacterial genomes are dedicated to encoding genes
necessary for tRNA nucleoside modifications (6), indicating the importance of such
modifications to cell function.
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Function of modified nucleosides
The structural complexities of many modified nucleosides, their locations in specific sites
in the tRNA molecule and their ubiquitous presence in a wide variety of organisms imply
a critical role in tRNA function. By the end of 2008, 107 structurally distinct modified
nucleosides had been identified from different RNAs from various Eukarya, Bacteria, or
Archaea. Some modifications are found in all the three domains while others are only
found in either one or two domains (5).

Modifications in the tRNA anticodon region are particularly prevalent and directly affect
tRNA function by modulating codon-anticodon interactions; 30-40% of all codon
recognition is accomplished through tRNA wobble recognition of more than one codon
(7). Many post-transcriptional modifications have been found to occur at the tRNA’s
wobble position 34 as well as position 37 (3’-adjacent to the anticodon); these are the two
most modified positions in tRNA with the greatest variety of modification chemistries
found among all tRNAs (7). Many modifications located outside of the anticodon region
function in general to stabilize the L-shaped tertiary structure of tRNA (8).

Some base modifications found at the wobble position appear to have evolved to counter
wobble base pairing while others evolved to facilitate it. Modifications in the anticodon
stem loop also aid in reading frame maintenance, promote translocation and cognate
codon binding, as well as changing the codon read (9) as in lysidine (k2C) (7). Lysidine
is a lysine (Lys)-containing cytidine derivative that occurs at the wobble position of
3

tRNAIle that bear the CAU anticodon in their tRNA sequence and are specific for the
AUA codon (7). The CAU anticodon also occurs in tRNAMet responsible for AUG
decoding. The lysidine modification converts the codon specificity of tRNA with the
CAU anticodon from AUG to AUA and the amino acid specificity from methionine
(Met) to isoleucine (Ile), thus preventing the misreading of AUA as Met (10).

Position 37 of the tRNA usually contains a modified purine nucleoside. Transfer RNAs
recognizing codons beginning with A usually have N6-threonylcarbamoyl-adenosine
(t6A) at this position (1). These modifications play a critical role in the stabilization of
codon-anticodon pairing through base-stacking interactions and function to maintain the
reading frame (1).

Another modification that occurs at this position is N1-methyl-

guanosine (m1G), which is conserved among the three domains of life (11). It has been
found to play various roles in different tRNAs. In bacterial tRNAPro, the methyl group at
the N1 position of G37 prevents incorrect base pairing with messenger RNA (12), it also
contributes to efficient and accurate aminoacylation. In archaeal tRNACysGCA m1G37
enhances the aminoacylation rates of phosphoseryl-tRNA synthetase (13, 14) and
cysteinyl-tRNA synthetase (13). Other functions of specific tRNA modifications include
HIV replication (m1A58) (15), cell cycle control (ms2i6A37) (16), and vitamin B6
metabolism (Ψ38-40) (17).
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1.2 Deazaguanosine derivatives: archaeosine and queuosine
Archaeosine and queuosine are two of the most structurally complex hypermodified
nucleosides identified in tRNA (Figure 1). Both modified nucleosides share the unusual
7-deazaguanosine core in which the N-7 atom of the base is replaced by a carbon.
Queuosine is characterized by a cyclopentenediol ring appended to 7-aminomethyl-7deazaguanosine (18, 19), whereas in archaeosine there is a formamidino side chain at
position 7 (20).

Archaeosine
Archaeosine (G+) occurs specifically at position 15 in the dihydrouridine loop of archael
tRNA, a site not modified in known bacterial and eukaryotic tRNA sequences.
Archaeosine was first discovered during the sequencing of tRNAMet from Thermoplasma
acidophilium (21). Its structure was shown to be neither purine nor pyrimidine but 7formamidino-7-deazaguanosine (20).

Tertiary base pairs are important to the structure of canonical tRNAs. Pairing of base 15
to 48 is crucial as it brings together the D and V loops, and is referred to as the Levitt
base pair (Figure 2). Nucleotides at positions 15 and 48 do not form the canonical
Watson-Crick base pairing, but form a reverse Watson-Crick (RWC) pairing (22). Proper
folding interactions in tRNAPhe from yeast has been shown to require G15-C48 base pair
for the correct interaction of the T and D arms (23). Magnesium binding and archaeosine
5

modification have been suggested to stabilize the Levitt base pair in tRNAs by inducing
electron redistribution, which results in stabilization of the RWC geometry (24) (Figure
3). The positively charged formamidine group of archaeosine at the interface of the Dloop/T-stem in the tertiary structure of the tRNA has also been suggested to be important
in structural stabilization of the tRNA through electrostatic interactions with the anionic
phosphates (20).

Queuosine
Queuosine (Q) and its derivatives are found at position 34 in tRNA with the GUN
anticodon (tRNAAsp,Asn,His,Tyr) (25-28) exclusively in bacteria and eukaryotes, with the
exception of Saccharomyces cerevisiae, Thermus thermophilus, mycobacterium and
mycoplasma. Queuosine can be further modified by the addition of a mannosyl group to
Q-tRNAAsp or galactosyl group to Q-tRNATyr in mammalian tRNA (29), or glutamate to
tRNAAsp in bacteria (30). Queuosine has been implicated in a number of physiological
phenomena including eukaryotic cell proliferation and differentiation (31), tyrosine
biosynthesis in mammals (32), translational frameshifts essential to retroviral protein
biosynthesis (33, 34) and bacterial virulence (35). In eukaryotes queuosine has been
further shown to be important in neoplasm staging (36). Most of the evidence to date
support the hypothesis that queuosine plays a role in modulating translational fidelity
(37). From experimental data (38) and computational modeling based on the crystal
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structure of tRNAAsp it appears that queuosine is structurally restrictive for anticodon
loop flexibility (36), which could function in eliminating codon bias.

1.3 Queuosine and archaeosine biosynthesis
The first step of Q and G+ biosynthesis in bacteria and archaea, respectively, follows the
pathway of pteridines and folic acid biosynthesis (39) as well as that of the 7-deazaadenine antitumor antibiotics such as toyocamycin (40), with GTP cyclohydrolase I
(GCYH-I) (41, 42) which catalyzes the conversion of GTP to 7,8-dihydroneopterin
triphosphate (H2NTP).

Comparative genomics resulted in identification of four genes (queC, queD, queE, and
queF), which are involved in the queuosine biosynthetic pathway of Bacillus subtilis (B.
subtilis) in a previously undefined operon (43). E. coli QueD was recently shown to
catalyze the conversion of 7,8-dihydroneopterin triphosphate to 6-carboxy-5,6,7,8-tetrahydropterin (CPH4) (44), which is then converted to the novel intermediate 7-carboxy-7deazaguanine (CDG) (45) by QueE, a member of the radical SAM enzyme superfamily.
Radical SAM proteins catalyze diverse reactions, including unusual methylations,
isomerization, sulfur insertion, ring formation, anaerobic oxidation and protein radical
formation (46). The carboxylate moiety on CDG is converted subsequently to a nitrile to
yield preQ0 by QueC an ATP-dependent reaction, in which ammonia serves as the
nitrogen source (45). The preQ0 biosynthetic pathway is shown in Figure 4.
7

The pathways for Q and G+ diverge after the formation of preQ0. In bacteria NADPH
dependent 7-cyano-7-deazaguanine oxidoreductase (QueF) catalyzes the NADPHdependent conversion of the nitrile moiety of preQ0 to the primary amine group in 7aminomethyl-7-deazaguanine (preQ1) (47). The bacterial tRNA-guanine transglycosylase (TGT) then introduces preQ1 into an appropriate tRNA with the concomitant release
of the genetically encoded guanine at position 34 (48). TGT catalyzes the base-exchange
reaction by cleaving the N-glycosidic bond, without breaking the phosphodiester
backbone (49).

The penultimate step is catalyzed by QueA which results in the

introduction of an epoxyclopentanediol ring to the primary amine of preQ1 forming the
intermediate epoxy-queuine (oQ) (50).

The final conversion to form the

cyclopentenediol of queuosine is catalyzed by an uncharacterized enzyme that may be
B12-dependent (51). Eubacteria are unique in their ability to synthesize queuosine de
novo, whereas eukaryotes utilize a salvage system or acquire queuine from their diet and
from intestinal flora (28, 52, 53), and insert this directly into tRNA by the eukaryotic
TGT (54).

In archaea, preQ0 is directly incorporated into the tRNA by an archaeal TGT, which
exchanges preQ0 for the guanine in position 15 of tRNA resulting in the formation of
preQ0-tRNA. In vitro guanine was found to be a substrate to archaeal TGT, but not
preQ1, archaeosine, and queuine (55). The biosynthetic pathways of archaeosine and
queuosine are shown in Figure 5. The enzyme responsible for the conversion of preQ0tRNA to G+-tRNA was unknown until the work reported in this thesis.
8

1.4 NADPH 7-cyano-7-deazaguanine oxidoreductase (QueF)
QueF is an oxidoreductase that utilizes two equivalents of NADPH in a four electron
reduction of the nitrile group of preQ0 to the primary amine of preQ1 (47). The reaction
catalyzed by QueF is shown in Figure 6. The amino acid sequence homology between
QueF and GTP cyclohydrolase I resulted in an initial mis-annotation of QueF as a GTP
cyclohydrolase (FolE) in the sequence databases.

The QueF family possess a

characteristic motif, named the QueF motif, E(S/L)K(S/A)hK(L/Y)(Y/F/W) where h is a
hydrophobic amino acid bracketed on the N- and C- terminal sides by at invariant Cys
and Glu, respectively. The QueF motif is absent from the FolE family, while key zinc
binding His and Cys residues found in the FolE family are absent from the QueF family;
these differences are the best identifiers of QueF sequences in genome databases (47).

Based on a homology model QueF was suggested to belong to the tunnel fold (T-fold)
family of proteins (56). The T-fold proteins bind substrates belonging to the purine and
pterin families.

The T-fold family is comprised of two structural subfamilies, the

unimodular and bimodular proteins. The unimodular proteins possess a single T-fold
domain and are comprised of approximately 160 amino acid residues. The bimodular
proteins however possess tandem T-fold domains and are comprised of approximately
280 amino acid residues (57). Functional assembly consists of 2 barrels face-to-face;
some structures of the T-fold proteins are shown in Figure 7.
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Substrate binding occurs at the interface of subunits and is anchored by a conserved Glu
/Gln; the presence of Glu/Gln in the active site is characteristic of T-fold proteins (57).
In dihydroneopterin aldolase (Glu74), 6- pyruvoyl tetrahydropterin synthase (Glu 107),
and urate oxidase (Gln 228), the conserved Glu/Gln is positioned such as to serve as an
acceptor for the pyrimidine ring of the substrate (57). In all of these examples, the
conserved Glu/Gln forms two hydrogen bonds to the substrate (57).

The discovery of QueF activity added a novel class of chemistry to nitrile metabolism
(Figure 8). The other pathways currently known in nitrile metabolism involve hydrolysis
by nitrile hydratase and nitrilase, and oxidation by oxygenase to give cyanohydrins (58).

1.5 S-Adenosylribosylmethionine:tRNA ribosyl transferase isomerase (QueA)

QueA catalyzes the penultimate step in the biosynthesis of queuosine, an unprecedented
transfer and isomerization of the ribosyl moiety from S-adenosylmethionine (AdoMet) to
preQ1-tRNA to give epoxyqueuosine modified tRNA, oQ-tRNA (Figure 10).

The

reaction is accompanied by the rearrangement of the ribosyl moiety and the elimination
of methionine and adenine (50, 59).

Kinetic analysis revealed that QueA follows an ordered sequential bi-ter mechanism in
which preQ1-tRNA binds to the enzyme followed by AdoMet to form a ternary complex,
followed by the transfer of the ribosyl group to preQ1 and release of products in the order
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adenine, methionine and oQ-tRNA (Figure 11) (60). The regiochemistry of the C-N
bond formation between preQ1-tRNA and AdoMet has been elucidated through the
utilization of [1´-13C] AdoMet in the QueA reaction followed by the identification of the
isotopically enriched carbon in the oQ nucleoside (61). NMR data supports C-3 as the
site of enrichment, implicating C-4´ of AdoMet as the site of C-N bond formation.

Two possible mechanisms are implicated, consistent with C-N bond formation at C4´. In
the mechanism (A) proposed for the reaction catalyzed by QueA (Figure 12) the first step
of the mechanism involves the deprotonation of AdoMet at C-5´ to give the sulfonium
ylide I. The subsequent opening of the ribose ring followed by elimination of adenine
generates the vinyl sulfonium II. Nucleophilic attack of the preQ1 methylamine at the C4´ position generates the sulfonium ylide III which subsequently attacks the C-1´
aldehyde to give the alkoxy-cabocycle IV. Intramolecular SN2 attack of the alkoxy
oxygen on the adjacent carbon results in the formation of oQ-tRNA and the elimination
of methionine (60). In mechanism (B) nucleophilic attack by the amine in an SN2
reaction forms the C-N bond in the first step before the C5´ proton is removed (Figure
12). The elimination/addition mechanism (mechanism A) is compatible with loss of
either proton since stereochemistry at C-5´ destroyed in the formation of the vinyl
sulfonium II.

But, elimination/addition mechanism requires either syn or anti

relationship between the proton removed and the C4´-O bond that is cleaved, the
conformations are shown in Figure 13. The conformation about the C4´-C5´ of bond
AdoMet, indicates that the reaction would most likely favor the trans conformation,
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resulting in the loss of the proS hydrogen, as this conformation is less sterically
demanding than the syn conformation. In contrast, an SN2 mechanism (mechanism B)
requires loss of C-5´-proR proton of AdoMet due to known streochemistry of oQ and the
stereochemical integrity of sulfonium ions. Thus, elucidating the stereochemistry of the
proton abstraction at C-5´ should allow one to distinguish between these mechanisms.

1.6 Objectives

The overall objectives of the work described in this thesis were to investigate several
enzymatic steps in the biosynthetic pathway leading to queuosine and archaeosine. The
work focused specifically on the following:

1. Methanocaldococcus jannaschii TgtA2
The objectives of this work were to test the hypothesis that tgtA2 encodes the enzyme
responsible for the final step of archaeosine biosynthesis, and to biochemically
characterize the enzyme.

2. NADPH 7-cyano-7-deazaguanine oxidoreductase (QueF)
The objectives of this work were to determine the elementary rate constants in the kinetic
mechanism of the reaction catalyzed by QueF (Figure 9), as well as identifying the rate
limiting step(s) in this reaction. In particular, to apply transient kinetic analyses to
12

elucidate the kinetics of substrate and cofactor binding, and the rates of thioimide
formation reduction.

As well as the investigation of the effects of ligands on its

quaternary structure.

3. S-Adenosylribosylmethionine:tRNA ribosyl transferase isomerase (QueA)
The objective of this work was to test two putative mechanisms for the QueA catalyzed
reaction by elucidating the stereochemistry of deprotonation at C5´ of AdoMet.
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2. MATERIAL AND METHODS

2.1 General methods and materials
Chemicals and reagents
Buffers, salts and reagents of the highest quality grade available were purchased from
Sigma (St. Louis, MO) unless otherwise noted. DEPC (diethylpyrocarbonate) treated
water was used in the preparation of all solutions for RNA related assays. Dithiothreitol
(DTT), isopropyl-β-D-thiogalacto-pyranoside (IPTG), kanamycin sulfate, β-NADPH (βNicotinamide adenine dinucleotide phosphate), β-NADP+, DEPC and ampicillin were
purchased from RPI Corporation (Chicago, IL). The radiochemicals [U-14C]-glucose, [814

C]-guanine,

[8-14C]-adenine,

[U-14C]-L-glutamine

and

[3H]-L-asparagine

were

purchased from Moravek (Brea, CA). Adenine, adenosine, guanosine, ATP, GTP, UTP,
CTP, methionine, ribose-5-phosphate, phospho(enol)pyruvate trisodium salt, and the
resins BND-cellulose, DEAE-cellulose, sephadex G25 and PEI cellulose TLC plates were
all purchased from Sigma. Nickel-nitrilotriacetic acid agarose (Ni2+-NTA agarose) was
purchased from Qiagen (Valencia, CA).

Silica TLC plates, Whatman GF-B and

Whatman P81 filter disks were purchased from Fisher Scientific (Pittsburgh, PA).
Centricon YM-10 and Amicon Ultra YM-10 centrifugal devices, Amicon Ultra-MC spin
filters and HA filters were from Millipore (Billerica, MA). Dialysis cassettes were
obtained from Pierce (Rockford, IL). Plasmid Mini-Kits were from Fermentas (Glen
Burnie, MD) and Qiagen. AntiRNase was purchased from Ambion, Inc (Austin, TX).
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Oligonucleotides were obtained from Integrated DNA Technologies (San Diego, CA).
The Bradford dye binding reagent from BioRad (Hercules, CA) was used for protein
determination.

All reagents for sodium dodecyl sulfate polyacrylamide gel

electrophoresis (SDS-PAGE) and 10% acrylamide/Tris-HCl precast gels were purchased
from BioRad. SDS-PAGE analysis was carried out using 12% gels and visualized with
Coomassie Brilliant Blue.

Invitrolon membranes (PDVF membranes) were from

Invitrogen. Gel filtration molecular weight standards were purchased from Sigma. The
mj1022 gene was custom synthesized by GenScript. DNA sequencing was carried out at
the DNA sequencing core facility at Oregon Health and Sciences University (OHSU),
Portland, OR. Edman degradation was carried out by the Molecular Structure Facility at
University of California, Davis. The LIC cloning kits containing either pET30Xa or
pET32Xa plasmids were from Novagen.

M. jannaschii genomic DNA was kindly

provided by Dr. Anna-Louise Reysenbach (Portland State University, Portland, OR).

Instrumentation
PCR was carried out on a GeneAmp PCR system 2400 from PerkinElmer Life Sciences.
UV-Vis spectroscopy was performed with a Varian Cary 100 spectrophotometer
equipped with a thermostated cell holder. Fluorescence spectroscopy was carried out on
a QM3 spectrofluorimeter from Photon Technology International and a Gemini XPS
microplate spectrofluorimeter from Molecular dynamics. HPLC was carried out using a
Hitachi L-7100 pump system with an L-4500A photodiode array detector, and controlled
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via the Hitachi ConcertChrome software. Centrifugation was carried out on an Avanti J20 centrifuge, an LE-80K Ultra centrifuge using a Ti-60 rotor, and a Model TJ 6
swinging bucket centrifuge, all from Beckman Coulter, Inc. SDS-PAGE was carried out
on a mini Protean III from BioRad. Small molecule mass spectrometry was performed
on a LCQ Advantage ion-trap mass spectrometer (Thermo Electron, San Jose, CA)
equipped with an electrospray ionization (ESI) source at the BioAnalytical Shared
Resource/Pharmacokinetics Core Facility in the Department of Physiology and
Pharmacology at OHSU, Portland, Oregon, or on a MicroTOF-Q tandem mass
spectrometry instrument (Bruker, Billerica, MA) utilizing ESI in the Department of
Chemistry at Portland State University. Radioactivity was quantified with a Beckman LS
6500 liquid scintillation counter. The pump used for column chromatography of RNA
was a Model EP-1 Econo pump and Econo-column from BioRad.

An Amersham

Biosciences Typhoon 9200 variable mode imager with ImageQuant 5.2 software was
used for phosphorimaging. Stopped flow experiments were carried out on both a HiTech Scientific SF 61-DX2 double mixing stopped flow spectrophotometer and Hi-Tech
Scientific SF-61 AF single mixing stopped flow spectrophotometer. The same 75 W
Xenon Arc lamp was used for both spectrophotometry and spectrofluorimetery.

Strains, media and growth conditions
DH5α (F- φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1 hsdR17(rk-, mk+) phoA
supE4 thi-1 gyrA96 relA1 tonA) (Invitrogen), NovaBlue (endA1 hsdR17 (rK12– mK12+)
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supE44 thi-1 recA1 gyrA96 relA1 lac F′[proA+B+ lacIqZ∆M15::Tn10(TetR)] (Novagen),
BL21 (DE3) F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene1 ind1
sam7 nin5]) (Novagen) were used for cloning or protein over-production, and were
routinely grown in LB medium (BD Diagnostic System) at 37˚C. Growth media were
solidified with 15 g/L agar for the preparation of plates. Transformation of E. coli was
performed following standard procedures. Ampicillin (amp, 100 µg/mL) and Kanamycin
(kan, 50 µg/mL), were used as needed.

Enzymes
Crude aminoacyl-tRNA synthetase from E. coli, L-glutamic dehydrogenase type I from
bovine liver, pyruvate kinase type II from rabbit muscle and bacterial alkaline
phosphatase were purchased from Sigma as ammonium sulfate suspensions.
Phosphoriboisomerase from torula yeast, hexokinase type F-300 from baker's yeast,
nuclease P1 from Penicillium citrinum, venom phophodiesterase I, lysozyme, and DNase
were purchased as lyophilized powders from Sigma and stored in 50% glycerol with the
appropriate buffer at the recommended temperature. PfuUltra™ DNA polymerase was
purchased from Stratagene. T4 DNA ligase and restriction enzymes were purchased
from Fermentas and New England Biolabs. Recombinant Saccharomyces cerevisiae
adenine phosphoribosyl-transferase (APT1) was expressed from pQEAPT1 in E. coli
BL25 (a generous gift from Dr. Milton Taylor, Indiana University). Recombinant 5phosphoribosyl-1-pyrophosphate (PRPP) synthetase from Salmonella typhimurium was
expressed from pBSR11R in E. coli JM831 (a gift from Dr. Vern L. Schramm, Albert
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Einstein University). Recombinant T7 polymerase was expressed from pT7-911Q in E.
coli DH5α. Recombinant S-adenosyl-methionine synthetase (MetK) was expressed in E.
coli DH5α from pK8 (pK8 was a gift from Dr. G. Markham, Fox Chase Cancer Center,
PA).

T7 polymerase expression and purification
Recombinant T7 polymerase was expressed in pT7-911Q/DH5α E. coli cells at 37 ºC in
LB/amp. Cells from a glycerol stock were used to inoculate 3 mL of LB/amp medium.
After 12 hours a 1 mL aliquot was removed and used to inoculate 100 mL of LB/amp
medium in 500 mL flasks. The cultures were incubated at 37 ºC and 250 rpm for 12
hours with shaking, after which 5 mL aliquots were taken and used to inoculate 500 mL
of LB/amp medium in 2.5 L flasks. After 3 hours of incubation at 37 ºC and shaking at
250 rpm an optical density at 600 nm (OD600) of about 0.9 was reached and IPTG was
added to a final concentration of 0.5 mM and the cells were grown for an additional 4
hours. The cells were collected by centrifugation at 7,500 x g for 15 minutes at 4 ºC and
frozen with liquid nitrogen. The cells were stored at -80 ºC until further use.

The cells were resuspended to 250 mg/mL in 50 mM Tris-HCl (pH 8.0), 100 mM KCl, 2
mM βME, 1 mM imidazole, and 1 mM PMSF.

Lysozyme was added to a final

concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by
3 intervals of freeze-thaw cycles. DNase was added to a final concentration of 10 µg/mL
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and the cells were left at 37 ºC for an additional 30 minutes. The cell lysate was
centrifuged at 26,000 x g for 30 minutes after which it was filtered through a low protein
binding 0.45 µm MCE filter. The CFE was loaded onto a 10 mL column containing
Ni2+-NTA agarose equilibrated in lysis buffer. The column was washed with lysis buffer
containing 10 mM imidazole. The recombinant T7 polymerase was eluted with 100 mM
imidazole in lysis buffer without PMSF. The collected eluate was concentrated to about
2 mL using the Amicon Ultra YM-10 and dialyzed overnight against 4 L of lysis buffer
without PMSF, then stored at -80 ºC as a 50% glycerol stock in aliquots of 100 µl.

PreQ0 semi-preparative HPLC purification
PreQ0 was synthesized as previously described by Migawa (62). PreQ0 was purified on a
semi-preparative Luna C18 column (250 x 10 mm, 5 µm) from Phenomenex. The preQ0
eluted in a 20 minute run, eluting at 12.5 minutes under gradient conditions; 96% 25 mM
NH4OAc (pH 6.0)/4% methanol for 10 minutes followed by a gradient of 96% 25 mM
NH4OAc/4% methanol up to 85% 25 mM NH4OAc/15% methanol over 10 minutes at a
flow rate of 4 mL/min .
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2.2 Methanocaldococcus jannaschii TgtA2 (MjTgtA2)
Cloning of MjTgtA2
The Methanocaldococcus jannaschii mj1022 gene corresponding to tgtA2 was amplified
from both genomic DNA and a custom synthesized gene (GenScript) via PCR and cloned
with either N- or C-terminal His6-fusions using the following primers:
Gen1022F

5’-GGTATTGAGGGTCGCATGCTCGAACCAATTG-3’

Gen1022R

5’-AGAGGAGAGTTAGAGCCTCAGCTTTTAACATTTC-3’

Syn1022F

5’-GGTATTGAGGGTCGCCATATGCTGGAACCG-3’

Syn1022R

5’-AGAGGAGAGTTAGAGCCGGATCCTTACG-3’

CterF

5’-GAAAACCATATGCTGGAACCGATTGCGTACG-3’

CterR

5’-GTGGTGCTCGAGCGATTTAACATTGCGAATATTC-3’.

Primers for amplification of mj1022 from genomic DNA (Gen1022) and the synthetic
gene (Syn1022) were designed for subsequent LIC cloning in pET32Xa with an Nterminal thioredoxin-His6-fusion (Trx-His6-fusion). The primers for amplification of the
synthetic gene with a C-terminal His6-fusion (Cter) contained the restriction sites
(underlined) for NdeI and XhoI to allow directional cloning into a pET30 vector. The
genes were amplified from genomic DNA (20 ng) or synthetic template (10 ng) with
PfuUltra™ DNA polymerase using the following program: 95 ºC (5 minutes), 30 cycles
of 95 ºC (30s), 60 ˚C (genomic DNA), 55 ˚C (synthetic gene, N-terminal fusion), or 57 ºC
(synthetic gene, C-terminal fusion) (30s), and 72 ºC (2 minutes), followed by a final
extension at 72 ºC for 10 minutes and hold at 4 ºC. Amplification of the genes for the
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construction of N-terminal fusions were followed by insertion of the PCR products into
pET32Xa following the manufacturer's instructions to give pVCII-120 (native gene) and
pVCIII-28 (synthetic gene). Amplification of the gene for construction of the C-terminal
fusion was followed by restriction digestion of the PCR product with NdeI/XhoI, gel
purification (1% agarose), and ligation into NdeI/XhoI digested pET30 using T4 DNA
ligase to give pVCIV-42. Plasmid DNA was isolated from all three constructs and the
primary structure of the genes confirmed by sequencing.

Overexpression and purification of recombinant MjTgtA2
The plasmids containing mjTgtA2 were transformed into E. coli BL21(DE3) for
expression of the variously tagged recombinant proteins. Cultures of transformed cells
were grown at 37 ˚C in either LB/kan or LB/amp with shaking (250 rpm) until an OD600
of 0.9 was obtained, IPTG was added to a final concentration of 0.25 mM, and the cells
were grown for an additional 4½ hours. The cells were collected by centrifugation at
7,500 x g for 15 minutes at 4 ºC and frozen with liquid nitrogen. The cells were stored at
-80 ºC until needed.

Frozen cell paste was suspended to 250 mg/mL in 50 mM HEPES (pH 7.0), 0.75 M
NaCl, 2 mM βME, and 1 mM PMSF. Lysozyme was added to a final concentration of
250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 3 intervals of
freeze thaw cycles. DNase was added to a final concentration of 10 µg/mL and the cells
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were left at 37 ºC for an additional 30 minutes. The cell lysate was centrifuged at 26,000
x g for 30 minutes at 4 ˚C, and the cell-free extract recovered and filtered (0.45 µm
MCE). The CFE was heated at 60 ºC for 15 minutes followed by centrifugation for 20
minutes at 20,000 x g; this cycle was repeated at 75 ºC. The heat-treated CFE was loaded
onto a column containing Ni2+-NTA agarose equilibrated in lysis buffer, and washed with
10 volumes of lysis buffer containing 25 mM imidazole but without PMSF. The TrxHis6 fusion protein was eluted with 250 mM imidazole in lysis buffer without PMSF.
The eluant was concentrated to 2 mL using the Amicon Ultra YM-10 and dialyzed
overnight against 4 L of lysis buffer without imidazole or PMSF. To remove the TrxHis6 affinity tag the fusion protein (20 mg) was incubated with Factor Xa (20 µg) at room
temperature in 100 mM Tris-HCl (pH 8.0), 0.5 M NaCl, 1 mM CaCl2, and 1 mM DTT for
~20 hours. The cleaved recombinant protein was then recovered after passing over a
Ni2+-NTA agarose column.

Edman Degradation of MjTgtA2
To allow the N- and C-terminal recombinant fusion proteins to self-cleave the Trx-His6MjTgtA2 and MjTgtA2-His6 fusion constructs (~100 µg each) were incubated in 100 mM
HEPES (pH 7.0), 0.5 M NaCl, and 2 mM BME at 4 ˚C for up to 4 weeks. The proteins
were then electrophoresed on a precast 10% acrylamide/Tris-HCl gel. Electroblotting
onto an Invitrolon membrane was carried out for 1 hour at 22 V according to the
manufacturer’s instructions using NuPAGE transfer buffer. The membrane was then
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stained with Coomassie blue followed by washing with 50% methanol, air-drying, and
specific bands analyzed by Edman sequencing.

Size exclusion chromatography
Size exclusion chromatography was used to determine the native molecular weight of
MjTgtA2 using a BioSep-Sec-4000 column (Phenomenex) with a mobile phase of 50 mM
phosphate (pH 7.2), 100 mM KCl and a flow rate of 1 mL/min. The void volume (V0)
and total bead volume (VT) were measured with blue dextran (2000 KDa) and potassium
ferricyanide (K3[Fe(CN)6] 329 Da).
standards.

The column was calibrated with MWGF1000

The partition coefficient (KD) values were calculated according to the

equation (Ve-V0)/(VT-V0) where Ve is the elution volume of the protein of interest, then
plotted vs. log MW to generate a standard curve.

Cloning and overexpression of MJTGT
The mj0436 gene corresponding to mjtgt was amplified from genomic M. jannaschii via
PCR with PfuUltra™ DNA polymerase using the following primers:
pET30-MJTGT-sense

5’-GGTATTGAGGGTCGCATGACTTTTGAGAT-3’

pET30-MJTGT-antisense

5’-AGAGGAGAGTTAGAGCCTCACTTATTTAT-3’.

The primers were designed for subsequent LIC cloning into pET30Xa. The genes were
amplified from 10 ng genomic DNA using the following program: 95 ºC (5 minutes), 30
cycles of 95 ºC (30s), 45 ºC (30s), and 72 ºC (2 minutes), followed by an extension at 72
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C for 10 minutes and hold at 4 ºC. Amplification of the gene was followed by insertion

of the PCR product into pET30Xa following the manufacturer's instructions to give
pVCV-39. Plasmid DNA was isolated and the primary structure of the genes confirmed
by sequencing.

Recombinant His6-MJTGT protein was expressed in pVCV-39/E. coli BL21(DE3) cells
at 37 ºC in LB/kan medium. LB/kan medium (3 mL) was inoculated from a single colony
of the cells, after 12 hours of incubation at 37 ºC; a 1 mL aliquot was used to inoculate
100 mL of LB/kan medium. The cultures were incubated at 37 ºC and 250 rpm for 12
hours and a 5 mL aliquot was taken and used to inoculate 500 mL of LB/kan medium.
After about 3 hours an OD600 of 0.9 was reached and protein over-expression was
induced by the addition of IPTG to a final concentration of 0.25 mM. The cell cultures
were grown for an additional 4-5 hours when the cells were collected by centrifugation at
7,500 x g for 15 minutes and frozen with liquid nitrogen. The cells were stored at -80 ºC
until further use.

The cells were resuspended to a density of 250 mg/mL in 50 mM Tris-HCl (pH 8.0), 300
mM KCl, 2 mM βME, and 1 mM PMSF. Lysozyme was added to a final concentration
of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 3 intervals of
freeze-thaw cycles. DNase was added to a final concentration of 10 µg/mL and the cells
were left at 37 ºC for an additional 30 minutes. The cell lysate was centrifuged at 26,000
x g for 30 minutes. The CFE was filtered using a low protein-binding 0.45 µm MCE
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syringe filter, then loaded onto 10 mL of Ni2+-NTA agarose resin equilibrated in 100 mM
Tris-HCl (pH 8.0), 300 mM KCl, 2 mM βME, and 1 mM PMSF (buffer A). The column
was washed with 5 column volumes of buffer A followed by 5 column volumes of buffer
A with 20 mM imidazole and no PMSF. The recombinant protein was eluted with 7
column volumes of buffer B containing 200 mM imidazole then concentrated to about 2
mL using the Amicon Ultra YM-10 and dialyzed overnight against 4 L of 50 mM TrisHCl (pH 8.0), 100 mM KCl, and 1 mM DTT at 4 ºC. The His6-MJTGT was cleaved by
Factor Xa and purified as previously described. The cleaved protein was stored in 50%
glycerol in 100 µL aliquots at -80 ºC.

In Vitro transcription of H. volcanii tRNASer
An RNA 76-mer corresponding to the sequence of the H. volcanii tRNASer was
transcribed in vitro from a template prepared from the pDF-II-42 plasmid after digestion
with MvaI. The H. volcanii tRNASer was synthesized in a reaction containing 80 mM
HEPES-KOH (pH 7.5), 12 mM MgCl2, 2 mM spermidine, 50 µg/mL BSA, 40 mM DTT,
0.01% Triton-X-100, 3 mM NTPs, 20 µg/mL template and 64 µg/mL recombinant T7
polymerase. The reaction was incubated at 37 ºC for 6 hours at which point the reaction
was stopped by heating at 95 ºC for 3 minutes, followed by centrifugation at 20,000 x g
for 10 minutes followed by precipitation with an equal volume of isopropanol.
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Purification of the tRNASer
The crude RNA was treated with RNase free DNase (40 Units/ml of the in vitro
transcription) in 40 mM Tris-HCl (pH 8.0), 10 mM NaCl, 6 mM MgCl2 and 10 mM
CaCl2, at 37 oC for 30 minutes. The RNA oligomer was purified by continuous elution
PAGE using the BioRad 491 Prep Cell and a 7 M urea, 10% acrylamide gel in the
following manner: approximately 10 mg of RNA in 50% formamide (v/v), 10 mM
EDTA, 0.1% (w/v) xylene cyanol FF, and 0.1% (w/v) bromophenol blue were loaded
onto the gel and the sample was electrophoresed at 300 V until the bromophenol blue was
eluting at which point fraction collection began. Fractions (5 mL) were collected at a
flow rate of 1 mL/min and the elution of the RNA was monitored on Urea/PAGE gels.
The fractions containing 76-mer were pooled and concentrated by lyophilizing to
dryness. The tRNA was resuspended in 3 mM sodium citrate (pH 6.3) and washed with a
10-fold volume of 3 mM sodium citrate (pH 6.3) using the Amicon Ultra YM-10 in order
to remove residual TBE.

Preparation of preQ0-tRNASer
PreQ0 was inserted into the tRNASer transcript by the native MJTGT. An aliquot of
MJTGT (10 µM) was added to a 1 mL solution containing 50 mM succinate (pH 5.5), 20
mM MgCl2, 100 mM KCl, 2 mM DTT, 100 µM tRNASer, and 1 mM preQ0. After 45
minutes at 80 ºC, the reaction was terminated by the addition of one-tenth volume of 2 M
NaOAc (pH 4.0) followed by one volume of water-saturated phenol and one fifth volume
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chloroform:isoamyl alcohol (49:1). After vortexing for 20s, the solution was centrifuged
in a swinging bucket rotor at 700 x g for 20 minutes. The aqueous phase was recovered
and applied directly to a Quick-Sep column containing 2 mL of Sephadex G-25. The
sample was centrifuged at 700 x g in a swinging bucket rotor for 1½ minutes to separate
the unreacted preQ0 and exchanged guanine from the preQ0-tRNASer. The preQ0-tRNASer
was precipitated from the eluate by the addition of 3 volumes of ethanol and cooling at 20 ºC for 2 hours. The solution was centrifuged at 20,000 x g for 20 minutes at 4 ˚C, the
supernatant removed, and the RNA pellet washed with 70% cold ethanol.

After

centrifugation again at 20,000 x g the supernatant solution was removed and the preQ0tRNASer was resuspended in 3 mM sodium citrate (pH 6.3) and stored at -20 ºC.

pH and temperature dependence of MjTgtA2 activity
The pH dependence of MjTgtA2 was investigated using the tri-buffer system composed
of 100 mM Tris/Mes/Acetate (pH 4.0 – 9.0), 0.5 M NaCl, 20 mM MgCl2, 1 mM DTT, 10
µM [U-14C]-L-glutamine, 20 µM preQ0-tRNASer, and MjTgtA2 (7.8 µg). The activity of
MjTgtA2 was also determined in several discrete buffers, including HEPES, phosphate,
citrate, and acetate. Assays were carried out at 40 ˚C, initiated with the addition of
MjTgtA2, and terminated after 10 minutes with the addition of 0.2 volume concentrated
NH4OH.
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Quantification of [U-14C]-L-glutamate formation was carried out as described above.
The temperature dependence of the reaction was determined in the presence of 100 mM
HEPES (pH 7.0), 0.5 M NaCl, 20 mM MgCl2, 1 mM DTT, 10 µM [U-14C]-L-Glutamine,
20 µM preQ0-tRNASer, and MjTgtA2 (7.8 µg). Assays were carried out as described
above with temperatures from 30 °C to 80 ˚C.

Glutaminase assays
Glutaminase activity was detected indirectly as a coupled assay to glutamate
dehydrogenase under continuous conditions. For coupled assays varying concentrations
of MjTgtA2 were incubated in the presence or absence of preQ0-tRNASer (10 µM) in an
assay solution containing 50 mM phosphate (pH 7.5), 0.5 M NaCl, 15 mM MgCl2, 1 mM
DTT, 2.5 mM Gln, 1 mM NADP+ and 4 U of glutamate dehydrogenase. Assays were run
at 37 ˚C with NADPH production monitored at 340 nm.

Direct assays of glutaminase activity were carried out for 10 minutes in 100 mM HEPES
(pH 7.0), 20 mM MgCl2, 0.5 M NaCl, 2 mM DTT, 12.4 µM [U-14C]-L-Gln, 50 µM
tRNASer with varying concentrations of MjTgtA2. The reactions were terminated by
addition of 0.2 volume concentrated NH4OH. A 6 µL portion of the assay was spotted
onto silica TLC plates and the plates developed in i-PrOH:NH4OH(conc) (7:3). The
plates were then analyzed on the Typhoon 9200.
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Amidotransferase assays
Assays of amidotransferase activity were carried out in 100 mM HEPES (pH 7.0), 0.5 M
NaCl, 20 mM MgCl2, 1 mM DTT, 10 µM MjTgtA2, 50 µM preQ0-tRNASer in the
presence of the 3 possible donors, NH4Cl (100 mM), Gln (5 mM) or Asn (5 mM). The
reaction was carried out at 40 ºC and stopped by the addition of 0.1 volume of 2 M
NH4OAc (pH 4.0) followed by one volume of water-saturated phenol and 0.2 volume
chloroform:isoamyl alcohol (49:1). After vortexing for 20s, the solution was centrifuged
in a swinging bucket rotor at 700 x g for 20 minutes. The aqueous phase was recovered
and the product G+-tRNASer was precipitated with 3 volumes of ethanol and placed at -20
º

C for 2 hours. The solution was centrifuged at 20,000 x g for 20 minutes at 4 ˚C, the

supernatant removed, and the RNA pellet washed with 70% cold ethanol. The solution
was centrifuged again at 20,000 x g for 20 minutes at 4 ºC, the supernatant removed, and
the RNA was resuspended to 3 µg/µL in H2O and digested as previously described (63).
Nucleosides were analyzed by HPLC using a Discovery HS C18 column (2.1 mm x 250
mM, Supelco), with a mobile phase comprised of a linear gradient from 100% 5 mM
NH4OAc (pH 5.3) to 85% 5 mM NH4OAc/15% acetonitrile developed over 30 minutes at
0.3 mL/min.

LCMS analysis of nucleosides was performed on a MicroTOF-Q tandem mass
spectrometry instrument (Bruker, Billerica, MA) utilizing electrospray ionization (ESI).
The ESI interface was operated in the positive mode using the following settings: end
plate offset −500 V, capillary voltage −4500 V, nebulizer gas 1.6 bar, dry gas 4 L/min,
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dry temperature 200˚C, funnel 1 RF 350 Vpp, funnel 2 RF 350 Vpp, hexapole RF
400 Vpp, collision energy 10 eV and collision RF 300 Vpp.
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2.3 NADPH 7-cyano-7-deazaguanine oxidoreductase

Expression and purification of wild type His6-QueF, His6-C55A and His6-E78A
mutants
Recombinant QueF (ykvM) was expressed in E. coli BL 21(DE3) cells with the plasmid
pET30-ykvM in LB/kan medium. The frozen cell stock was used to inoculate 3 mL of
LB/kan medium. After 12 hours of incubation at 37 ºC, a 1 mL aliquot was removed and
used to inoculate 100 mL of LB/kan medium in a 500 mL flask. The cultures were
incubated at 37 ºC and 250 rpm for 12 hours and 5 mL aliquots were removed and used to
inoculate 500 mL of LB/kan medium in 2.5 L flasks. When an OD600 of 0.9 was reached,
protein over-expression was induced by the addition of IPTG to a final concentration of
0.5 mM. The cell cultures were grown for an additional 4 hours at which time the cells
were collected by centrifugation at 7,500 x g for 10 minutes at 4 ºC and frozen with liquid
nitrogen. Typically 20 g of cells were obtained from 4 L of media. The cells were stored
at -80 ºC until further use. The expression of the mutants was carried out as described for
the wild-type protein.

The cells were resuspended to a density of 250 mg/mL in 100 mM Tris-HCl (pH 8.0),
100 mM KCl, 1 mM βME, and 1 mM PMSF.

Lysozyme was added to a final

concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by
3 intervals of freeze thaw cycles. DNase was added to a final concentration of 10 µg/mL
and the cells were left at 37 ºC for an additional 30 minutes. The cell lysate was
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centrifuged at 26,000 x g for 30 minutes. The CFE was filtered using a low proteinbinding 0.45 µm MCE syringe filter, then loaded onto 10 mL of Ni2+-NTA agarose resin
equilibrated in 100 mM Tris-HCl (pH 8.0), 100 mM KCl, 1 mM βME, and 1 mM PMSF
(buffer A). For all the mutants only 2 mL of the Ni2+-NTA agarose was used. The
columns were washed with: 5 column volumes buffer A followed by 5 column volumes
buffer A with 20 mM imidazole (buffer B) and finally with 5 column volumes of buffer
A with no PMSF but with 50 mM imidazole (buffer C). The recombinant fusion proteins
were eluted with 5 column volumes of buffer C containing 200 mM imidazole (Buffer D)
to about 2 mL using the Amicon Ultra YM-10 and dialyzed overnight against 4 L of 100
mM Tris-HCl (pH 8.0), 100 mM KCl, and 1 mM DTT at 4 ºC (Buffer E). Following
dialysis the recombinant fusion proteins were treated with Factor Xa.

Purification of QueF proteins
Factor Xa (10 µg) was added to 20 mg of purified QueF protein and the digestion was
carried out in the presence of 100 mM Tris-HCl (pH 8.0), 100 mM KCl, 1 mM CaCl2,
and 1 mM βME. The digestion was carried out for 20 hours at room temperature after
which the digestion reaction was loaded onto a Ni2+-NTA agarose column that had been
equilibrated in 100 mM Tris-HCl (pH 8.0), 100 mM KCl, and 1 mM βME (Buffer F).
The cleaved wild type protein was eluted with 5 column volumes of buffer F. The
protein was concentrated as previously described and stored in aliquots of 100 µL at - 80
º

C in the presence of 50% glycerol. The same procedure was repeated for the mutants.
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Preparation of glassware for metal analysis and apoprotein preparation
Glassware and plasticware to be used in the analysis was soaked in 10% nitric acid for 48
hours. This was followed by repeated soaking in 5 mM EDTA for 2 hours in the
presence of chelex resin (3x total). Chelex-treated water was used for the preparation of
all the buffers and salts for the apoprotein preparation as well as the subsequent analysis.
Native QueF was dialyzed against 4 L of 100 mM Tris-HCl (pH 8.0), 0.5 M KCl, 1 mM
βME, 10 mM EDTA, and 2 g of chelex for 24 hours. This was followed by a second
dialysis in the presence of 2 L 100 mM Tris-HCl (pH 8.0), 200 mM KCl, 1 mM βME,
and 1 g chelex for 24 hours. The final dialysis was carried out in 2 L of 100 mM TrisHCl (pH 8.0), 100 mM KCl, and 1 mM βME for 2 hours.

Determination of the effect of metals on QueF activity
The activity of the native QueF was determined in the presence of Mn2+, Cu2+, Ca2+, Zn2+
and Mg2+, and in the presence of EDTA. The concentration of the metals was varied from
0 to 10 mM. The reaction conditions were 100 mM Tris-HCl (pH 7.5), 100 mM KCl, 1
mM DTT, 80 µM NADPH, 150 µM preQ0, 1 µM QueF, and the divalent metal (varied).
The reactions were carried out at 30 ºC and monitored by following the depletion of
NADPH at 340 nm.

The effect of KCl concentration on QueF activity was determined on both the native and
"apparent apoprotein". Three concentrations of KCl were tested, 10 mM, 50 mM and
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100 mM. The reaction conditions were 100 mM Tris-HCl pH (7.5), 1 mM DTT, 80 µM
NADPH, 150 µM preQ0, 250 µM MnCl2, 1 µM QueF, and KCl (varied).

pH profile determination
The effect of pH on the activity of QueF was examined using the following buffers; MES
(pH 5.75 - 6.67), Tris-HCl (pH 7.0 - 8.0), and potassium phosphate (5.8 - 8.0). The
following reaction conditions were used: 100 mM Buffer, 50 mM KCl, 1 mM DTT, 80
µM β-NADPH, 100 µM preQ0, 2 µM QueF, and 250 µM MnCl2. The reactions were
carried out at 30 ºC and initiated by QueF addition in a final volume of 200 µL. The
reaction was monitored by following the depletion of NADPH at 340 nm.

Size exclusion chromatography
Size exclusion chromatography was used to determine the effect of ligands and salts on
the quaternary structure of QueF using a BioSep-Sec-4000 column (Phenomenex) with a
mobile phase of 25 mM phosphate (pH 7.2), 25 mM KCl, and a flow rate of 1 mL/min.
The change in the retention time of QueF was analyzed in the presence of MnCl2 or
MgCl2, varying concentrations at KCl and in the presence of preQ0. The QueF was
incubated with preQ0 at least 10 minutes before analysis. However, for analyzing the
effect of KCl on quaternary structure the protein was incubated for 3 hours in the
presence of 0.5 M KCl and 10 mM EDTA, and the KCl effect was determined using a
mobile phase of 25 mM phosphate (pH 7.2), 0.5 M KCl.
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Development of fluorescence assays for use in stopped flow kinetics
Fluorescence of the single tryptophan residue of QueF was determined by excitation at
295 nm and emission between 305 - 450 nm. The fluorescence was determined in the
presence of 50 mM phosphate (pH 6.5), 50 mM KCl, 1 mM DTT, 250 µM MnCl2, 80 µM
QueF, and 100 µM preQ0 and without preQ0. Fluorescence of NADPH was determined
in the presence of QueF and preQ0 by excitation at 340 nm and the emission from 360 nm
to 700 nm.

Transient kinetics

Rapid kinetic studies were performed using a double-mixing Hi-Tech Scientific
(Salisbury, Wiltshire, UK) model SF-61 DX2 stopped-flow spectrophotometer/
fluorimeter controlled by KinetAsyst (version 3.16; Hi-Tech Scientific). Fluorescence
and absorbance measurements were determined in single mixing mode (observation cell
optical path-length of 1 cm), equipped with a 75 W short arc mercury lamp. Some of the
absorbance based kinetics experiments were also performed on a Hi-Tech Scientific SF61 AF single mixing stopped flow spectrophotometer. The reactions were carried out
with a final volume of 120 µL from solutions driven from high performance syringes
through a high efficiency mixer. The resultant mixture passed through the measurement
flow cell and into a stopping syringe. Steady flow of the mixture was achieved just
before stopping. A schematic of a stopped flow instrument is shown in Figure 15.
Temperature was controlled using a circulating waterbath. Apparent rate constants (kobs)
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from kinetic traces were calculated using the KaleidaGraph software and rate constants
were determined by use of Dynafit through global analysis of the data.

Thioimide formation

The kinetics of formation of the thioimide between QueF and preQ0 were measured using
stopped-flow spectrophotometry. One syringe was filled with solution A (124 µM QueF,
50 mM potassium phosphate (pH 6.5), 50 mM KCl, 250 µM MnCl2, and 1 mM DTT),
whereas the second syringe was filled with solution B (i.e. solution A without QueF).
Equal volumes (60 µL each) of solution A were mixed with solution B. Five or more
shots were performed to flush the stopped-flow lines and to obtain a baseline. After the
flushing was complete, the solution B in the second syringe was replaced with solution B
containing preQ0 (solution C), and several shots were performed with varying
concentrations of preQ0. The final concentrations of preQ0 in the reactions were 11.8,
17.0, 21.5, 26.3, 37.7, 51.0 µM, and QueF final concentration was 62 µM. The reactions
were carried out at 30 ºC and monitored at 370 nm for 5 seconds. The data was fit to
single and double exponential rise equations using KaleidaGraph;

y = A(1-exp(-kobst)) + a

y = A1 (1-exp(-kobs1t)) + A2(1-exp(-kobs2t)) + a
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where y is the absorbance signal, A, A1, A2, are the amplitudes, a is the offset, and kobs,
kobs1 and kobs2 are apparent rate constants. Global data analysis was also carried out using
DynaFit (Equations). The rates of the spectral changes at 370 nm were obtained from the
best fits with the smallest residuals.

Transient kinetics of substrate binding

PreQ0 binding to wild-type and C55A QueF was measured using stopped-flow
fluorescence spectroscopy by monitoring the intrinsic tryptophan fluorescence under
pseudo first order conditions, where the QueF concentration was maintained high and
preQ0 concentration was varied. The excitation wavelength was 295 nm, and emission
was observed at 334 nm (a 334±5 nm band pass emission filter was used, Edmund Optics
Inc, USA). For each experimental condition 12 shots were carried out and averaged. The
fluorescence of the QueF solution without preQ0 was measured before the
commencement of the experiment and was set as the 100% fluorescent signal. The
reactions were carried out at 20 ºC in the presence of 50 mM potassium phosphate buffer
(pH 6.5), 50 mM KCl, 250 µM MnCl2, and 1 mM DTT. For the analysis of preQ0
binding to wild type QueF the final concentrations in reactions were 200 µM QueF and
preQ0 (5.3, 15.4, 22.6, 30.4 µM). PreQ0 binding to C55A was determined in the presence
of 200 µM QueF, and preQ0 (6.8, 11.8, 18.2, 23.3, 29.2, 38.8, 50.0 µM). The QueF
concentration was kept high and the preQ0 concentration was varied. At least 512 points
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were collected in each trace. The data was fit to single and double exponential decay
equations using KaleidaGraph;
y = Aexp(-kobst) + a

y = A1exp(-kobs1t) + A2exp(-kobs2t) + a

where y is the absorbance signal, A, A1, A2, are the amplitudes, a is the offset, and kobs,
kobs1 and kobs2 are apparent rate constants. Global analysis was again carried out using
Dynafit.

NADPH binding kinetics were also determined for the QueF mutant, E78A, which is
capable of forming the thioimide bond but unable to facilitate its reduction. The binding
was directly monitored by following the intrinsic NADPH fluorescence with excitation at
340 nm and emission was monitored by using a 455 nm long pass filter. The reaction
was carried out at 20 ºC, 50 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250
µM MnCl2, and 1 mM DTT. The E78A QueF mutant (200 µM) was preincubated with
700 µM preQ0 for at least 10 minutes before mixing with varying concentrations of
NADPH. The final concentrations of NADPH in the assays were; 16.0, 23.5, 31.8, 39.4,
50.3, 57.4, 69.3 µM, and the E78A QueF-*PreQ0 was 100 µM.

Transient kinetics of thioimide reduction

Reduction of the thioimide bond was monitored under single turnover conditions by
using both the intrinsic NADPH fluorescence with excitation at 340 nm and the emission
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was monitored by using a 455 nm long pass filter as well as by monitoring the loss of the
thioimide absorption at 390 nm. The change in signal was monitored upon rapid mixing
of equal volumes of premixed QueF-*PreQ0 solution from one syringe and varying
concentrations of NADPH from the second syringe. For the fluorescence analysis the
reaction was carried out at 20 ºC in 50 mM potassium phosphate buffer (pH 6.5), 50 mM
KCl, 250 µM MnCl2, and 1 mM DTT. QueF was (145 µM) was preincubated with 300
µM preQ0 for at least 10 minutes before mixing with varying concentrations of NADPH.
The final concentrations of NADPH in the assay were 8; 16, 23.5 µM, and the QueF*PreQ0 was 72.5 µM. For absorbance assays the reaction was carried out at 30 ºC in 50
mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 µM MnCl2, and 1 mM DTT,
with final concentration of QueF-*PreQ0 at 180 µM in the presence of 20 and 26.3 µM
NADPH.

Thioimide decomposition
Thioimide decomposition was monitored at 370 nm at 30 ºC on the Cary 100
spectrophotometer. The reactions were carried out in the presence of 50 mM potassium
phosphate buffer (pH 6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT, ~ 154, 158 and 161
µM QueF-*PreQ0. For the preparation of the thioimide 1 mL of 200 µM QueF and 600
µM preQ0 were mixed and incubated for at least 10 minutes before the excess preQ0 was
removed by either dialysis against 4 L of 50 mM phosphate (pH 6.5), 50 mM KCl, 250
µM MnCl2, and 1 mM DTT or by 3 consecutive buffer exchanges with the dialysis buffer
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resulting in a 1000 times dilution. The resulting covalent QueF-*PreQ0 complex was
then monitored for at least 8 hours with either 5 or 10 minute intervals using multiple
scanning kinetics.
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2.4 S-Adenosylribosylmethionine:tRNA ribosyl transferase isomerase
Expression and purification of His6-QueA
Recombinant QueA was expressed in pET30-QueA/BL21(DE3) E. coli cells at 37 ºC in
LB/kan medium. Cells from a glycerol stock were used to inoculate 3 mL of LB/kan
medium. After 12 hours a 1 mL aliquot was removed and used to inoculate 100 mL of
LB/kan medium in 500 mL flasks. The cultures were incubated at 37 ºC and 250 rpm for
12 hours, after which 5 mL aliquots were taken and used to inoculate 500 mL of LB/kan
media in 2.5 L flasks. After 3½ hours of incubation at 37 ºC with shaking at 250 rpm an
OD600 of about 0.9 was reached, IPTG was added to a final concentration of 0.2 mM, and
the cells were grown for an additional 4 hours. The cells were collected by centrifugation
at 7,500 x g for 15 minutes at 4 ºC and frozen with liquid nitrogen. The cells were stored
at -80 ºC until further use.

Cells were resuspended to a density of 250 mg/mL in 50 mM Tris-acetate buffer (pH
8.0), 50 mM KCl, 2 mM βME, and 1 mM PMSF. The cells were lysed by the addition of
lysozyme to a final concentration of 250 µg/mL and lysis was carried out for 30 minutes
at 37 ºC. After which, one-fourth volume of chilled 400 mM Tris-acetate (pH 8.0), 1.2 M
KCl, 8 mM βME, 4 mM PMSF, 4% Triton-X-100 and 40% glycerol was added to the
mixture and placed on ice for 5 minutes. The cell lysate was centrifuged at 26,000 x g for
30 minutes at 4 ºC, after which the CFE was filtered through a 0.45 µm MCE syringe
filter.
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The CFE was loaded onto a column containing 10 mL of Ni2+-NTA agarose resin
equilibrated in 100 mM Tris-acetate (pH 8.0), 300 mM KCl, 2 mM βME, 1% Triton-X100 and 10% glycerol (buffer A). The column was washed with 5 column volumes
buffer A followed by 5 column volumes of buffer A with 20 mM imidazole (buffer B)
and finally by 5 column volumes of buffer B without the triton X-100 or PMSF (buffer
C). Protein elution was carried out with 7 column volumes of buffer C containing 200
mM imidazole (buffer D). The protein was concentrated to about 1 mL using an Amicon
Ultra YM-10 and dialyzed overnight against 4 L of 50 mM Tris acetate (pH 8.0), 50 mM
KCl, and 1 mM DTT at 4 ºC. The protein determination was carried out using the
Bradford method and protein purity was verified by use of SDS-PAGE. The protein was
stored in aliquots of 100 µL at - 80 ºC in the presence of 50% glycerol.

Assays for QueA activity were carried out in 100 mM Gly-gly (pH 8.7), 100 mM EDTA
(pH 8.7), 100 mM KCl, 1 mM DTT, and 20 µM tRNATyr, 200 µM [U-ribosyl-14C]AdoMet and 1 µM QueA.

The reactions were carried out in 50 µL volumes and

terminated by the addition of 4 volumes of 10% TCA and left to stand on ice for at least
ten minutes before collecting the precipitated tRNA on Whatman GF-C fibers by vacuum
filtration. The filters were washed with at least a liter of 5% TCA followed by 95%
ethanol, air dried and the radioactivity quantified by liquid scintillation counting
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Expression and purification of E. coli tRNA-Guanine Transglycosylase (TGT)
The recombinant E. coli TGT was expressed in E. coli BL21(DE3) with the plasmid
pET30-Ectgt in LB/kan medium.

Cells from a frozen glycerol stock were used to

inoculate 3 mL of LB/kan medium. After 12 hours of incubation at 37 ºC, 1 mL aliquot
was used to inoculate 100 mL of LB/kan medium. The cultures were incubated at 37 ºC
and 250 rpm for 12 hours and 5 mL aliquot was taken and used to inoculate 500 mL of
LB/kan medium. After about 3 hours an OD600 of 0.9 was reached and protein overexpression was induced by the addition of IPTG to a final concentration of 0.2 mM. The
cell cultures were grown for an additional 4-5 hours, after which the cells were collected
by centrifugation at 5,000 x g for 15 minutes and frozen with liquid nitrogen. The cells
were stored at -80 ºC until further use.

The cells were resuspended to a density of 250 mg/mL in 50 mM Tris-acetate (pH 7.5),
50 mM KCl, 2 mM βME, and 1 mM PMSF.

Lysozyme was added to a final

concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by
3 intervals of freeze thaw cycles. DNase was added to a final concentration of 10 µg/mL
and the cells were left at 37 ºC for an additional 30 minutes. The cell lysate was
centrifuged at 26,000 x g for 30 minutes. The CFE was filtered using a low proteinbinding 0.45 µm MCE syringe filter, then loaded onto 10 mL of Ni2+-NTA agarose resin
equilibrated in 100 mM Tris-acetate (pH 7.5), 300 mM KCl, 2 mM βME, 4 mM PMSF,
1% Triton X-100, and 10% glycerol ( buffer A). The column was washed with 5 column
volumes buffer A with 20 mM imidazole (buffer B) followed by 5 column volumes
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buffer B with no Triton X-100 or PMSF (buffer C). The fusion protein was eluted with 7
column volumes of buffer C containing 200 mM imidazole (buffer D), then concentrated
to about 2 mL using the Amicon Ultra YM-10 and dialyzed overnight against 4 L of 50
mM Tris-acetate (pH 7.5), 50 mM KCl, and 2 mM DTT at 4 ºC. The protein was stored
in the presence of 50% glycerol in 100 µL aliquots at -80 ºC. Activity was measured as
previously described (48).

Adenine phosphoribosyltransferase (APRTase) expression and purification
Recombinant APRTase was expressed from pQE-APT1 in E. coli B25 cells as a Histagged protein. Cell cultures were grown at 37 ºC in 2xYT medium containing 100
µg/mL ampicillin and 25 µg/mL kanamycin. The cells were grown in 3 mL cultures at
37 ºC for 12 hours and 250 rpm, after which 1 mL was taken and used to inoculate 100
mL of 2xYT/kan/amp medium and left to grow for another 12 hours. Erlenmeyer flasks
containing 500 mL of 2xYT/kan/amp medium were inoculated with 5 mL of the 100 mL
culture and left to grow until the OD600 had reached about 0.9 at which point the protein
over-expression was induced by the addition of 0.25 mM IPTG. The cell cultures were
left to grow for an additional 4 hours after which they were harvested by centrifugation at
7,500 x g for 15 minutes and frozen immediately with liquid nitrogen. The cells were
stored at -80 ºC until further use. Approximately 14 g of cells were obtained from 4 L of
cell culture.
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The cells were resuspended to a final density of 250 mg/mL in lysis buffer of 50 mM
Tris-HCl (pH 7.4), 5 mM MgCl2 and 20 mM KCl. Lysozyme was added to a final
concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by
3 intervals of freeze thaw cycles. DNase was added to a final concentration of 10 µg/mL
and the cells were left at 37 ºC for an additional 30 minutes. The cell lysate was
centrifuged at 26,000 x g for 30 minutes. The CFE was filtered using a low proteinbinding 0.45 µm MCE syringe filter, then loaded onto 10 ml of Ni2+-NTA agarose resin,
which had been previously equilibrated in lysis buffer. The column was washed with 10
column volumes of lysis buffer containing 50 mM imidazole followed by elution with 4
column volumes using lysis buffer containing 150 mM imidazole. The protein was
concentrated using an Amicon Ultra YM-10 centrifugal device at 4 ºC. The sample was
dialyzed overnight against 4 L of the same buffer without imidazole and stored as a 50%
glycerol stock. Protein purity was confirmed by SDS-PAGE.

The activity of the purified protein was assayed in a solution containing, 50 mM Tris-HCl
(pH 7.0), 8 mM MgSO4, 1 mg/mL BSA, 200 µM [8-14C]Adenine, 5 µg/mL of PRPP, and
2 µg APRTase. The assay was carried out at room temperature in 100 µL reaction
volume and the formation of AMP was monitored by the removal of 15 µl aliquots,
quenching with the addition of EDTA to a final concentration of 100 mM and applied
onto DE-81 filters. The filters were washed with distilled water and placed in vials with
scintillation fluid and counted.
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5-phosphoribosyl-1-pyrophosphate (PRPP) synthetase expression and purification
E. coli cells JM831 containing the pBSR11R plasmids were expressed in LB/amp
medium at 37 ºC. Cells from a glycerol stock were used to inoculate 3 mL of LB/amp
medium and were grown for 12 hours at 37 ºC and 250 rpm, after which 1 mL was taken
and used to inoculate 100 mL LB/amp medium and left to grow for 12 hours at 37 ºC at
250 rpm. Erlenmeyer flasks containing 500 mL of LB/amp medium were inoculated with
5 mL of the 100 mL culture and left to grow at 37 ºC and 250 rpm until the OD600 had
reached about 0.9 at which point the protein expression was induced by the addition of
0.25 mM IPTG. The cell cultures were left to grow for an additional 4 hours after which
they were harvested by centrifugation at 5,000 x g for 15 minutes and frozen immediately
with liquid nitrogen. The cells were stored at -80 ºC until further use. Approximately 20
g of cells were obtained from 3.5 L of cell culture.

The cells were resuspended to a final concentration of 250 mg/mL in 50 mM potassium
phosphate (pH 7.5), 2 mM DTT, and 1 mM PMSF. Lysozyme was added to a final
concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by
3 intervals of freeze thaw cycles. DNase was added to a final concentration of 10 µg/mL
and the cells were left at 37 ºC for an additional 30 minutes. The cell lysate was
centrifuged at 26,000 x g for 30 minutes. The CFE was filtered using a low proteinbinding 0.45 µm MCE filter. The PRPP synthetase was precipitated out by slow addition
of small amounts of ammonium sulfate over an hour to a final concentration of 15% with
constant swirling. The precipitated protein was left to stand on ice for an additional 30
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minutes after which it was pelleted by centrifugation at 26,000 x g for 30 minutes at 4 ºC.
The pellet was resuspended in an equal volume of the lysis buffer used to suspend the E.
coli cells used to prepare the lysate, and the protein was concentrated using an Amicon
Ultra YM-10 centrifugal device at 4 ºC. The sample was dialyzed overnight and against
the same buffer and stored as a 50% glycerol stock. Activity was assessed as previously
described (64).

S-adenosylmethionine synthetase (MetK) expression and purification
Recombinant MetK was over-expressed from E. coli DH5α/pK8. Cell cultures were all
grown at 37 ºC in LB/amp medium. Cells from a glycerol stock were used to inoculate 3
mL of LB/amp medium and were grown for 12 hours at 37 ºC and 250 rpm, after which 1
mL was taken and used to inoculate 100 mL LB/amp medium and left to grow for 12
hours at 37 ºC at 250 rpm. Erlenmeyer flasks containing 500 mL of LB/amp medium
were inoculated with 5 mL of the 100 mL culture and left to grow at 37 ºC and 250 rpm
until the OD600 had reached about 0.8 at which point the protein expression was induced
by the addition of 1 mM IPTG. The cells were harvested by centrifugation at 5,000 x g
for 10 minutes, after which they were frozen with liquid nitrogen. About 12 g of cells
were obtained from 3.5 L of media.

The cells were resuspended in 50 mM Tris-HCl (pH 8.0), 0.5 mM EDTA and 1 mM
PMSF.

Lysozyme was added to a final concentration of 250 µg/mL and the cells
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incubated at 37 ˚C for 30 minutes, followed by 3 intervals of freeze thaw cycles. DNase
was added to a final concentration of 10 µg/mL and the cells were left at 37 ºC for an
additional 30 minutes. The cell lysate was centrifuged at 26,000 x g for 30 minutes. The
cell-free extract was filtered by a low protein binding 0.45 µm MCE syringe filter. MetK
was precipitated with ammonium sulfate at a final concentration of 65%.

The

precipitated enzyme was collected by centrifugation and resuspended in 50 mM Tris-HCl
(pH 8.0), 0.5 mM EDTA (pH 8.0), and 1 mM PMSF and concentrated to about 2 mL
using the Amicon YM-10. The protein was dialyzed overnight against 4 L of lysis buffer
and stored in 50% of glycerol at -80 ºC.

Protein activity was assayed by monitoring the conversion of [1-14C-]-L-methionine and
ATP to [1-14C-]-AdoMet. The reaction conditions were 100 mM Tris-HCl (pH 8.0), 100
mM KCl, 10 mM MgCl2 and 2 mM [1-14C-]-L-methionine. The reactions were carried
out at room temperature for 1 hour and stopped by addition of 100 mM EDTA. The
reaction mixture was placed on Whatman p-81 filters and washed with at least 500 mL of
distilled water before being placed in scintillation vials and counted.

Preparation and purification of [U-ribosyl-14C] ATP
Synthesis of [U-ribosyl-14C]-ATP was carried by using 7 commercially available
enzymes and 2 in-house purified enzymes and [U-14C]-glucose. The synthesis was
carried out as previously described (65, 66) with a few modifications. A single reaction
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mixture of 1 mL contained 200 µM [U-14C]-glucose, 50 mM potassium phosphate (pH
7.5), 50 mM gly-gly (pH 8.7) , 10 mM MgCl2, 3 mM adenine, 20 mM PEP, 1 mM
NADP+, 1 mM ATP , 10 mM α-ketoglutarate, 0.8 U of glusoe-6-phosphate dehydrogenase, 0.8 U of phosphogluconate dehydrogenase, 8 U of phosphoribisomerase, 100 µg of
5-phosphoribosyl-1-pyrophosphate synthetase, 25 µg of adenine phosphoribosyltransferase, 8 U of myokinase, 16 U of pyruvate kinase and 8 U of hexokinase. All these
enzymes were combined and washed with 10 ml of 10 mM phosphate buffer (pH 7.5) and
concentrated in a Centricon YM-10 unit to remove salts. Glutamate dehydrogenase was
added to provide a final concentration of 50 mM NH4+ required as a substrate by
glutamate dehydrogenase. The reaction was carried out at 37 ºC for about 4 hours, and
was monitored by TLC analysis on PEI cellulose, which was cut into 1 cm strips as the
reaction proceeded. The reaction was terminated by heating to 95 ºC for 3 min followed
by centrifugation at 20,000 x g for 20 minutes.

Purification of [U-ribosyl-14C]ATP was carried out on a C18 reverse-phase HPLC with a
semi preparative Hypersil 5 C18 column (250 x 10 mm, 5 µm, phenomenex) (66). The
ATP was eluted under isocratic conditions of 94% 83.3 mM triethylammonium acetate
(pH 6.0)/6% methanol at a flow rate of 4 mL/min. The ATP fractions were pooled and
lyophilized to dryness and dissolved in water. The concentration of ATP was determined
by UV spectroscopy at 260 nm (ε260 = 15.4 x 103 M-1 cm-1).
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Synthesis and purification of unlabelled and [U-ribosyl-14C]-AdoMet
The purified [U-ribosyl-14C]-ATP was used in an enzymatic step to produce [U-ribosyl14

C]-Adomet (67). The reaction was carried out in 100 mM Tris-HCl (pH 8.0), 50 mM

KCl, 26 mM MgCl2, 5 mM DTT, 5 mM methionine, 1 mM [U-ribosyl-14C]-ATP, 20%
acetonitrile, and 1.0 mg/mL of MetK.

The reaction was monitored as previously

described. The reaction was terminated by the addition of cold tricholoroacetic (TCA)
acid to a final concentration of 8% (w/v). After centrifugation at 20,000 x g for 30
minutes, the synthesized AdoMet was purified from ATP by reversed phase HPLC using
a semi-preparative Hypersil 5 C18 column (250 x 10 mm, 5 µm, Phenomenex). The [Uribosyl-14C]-AdoMet was eluted under isocratic conditions of 98% 20 mM ammonium
acetate (pH 6.0)/2% Methanol. The [U-ribosyl-14C]-AdoMet fractions were immediately
collected and acidified by addition of H2SO4 and lyophilized to dryness.

The

concentration was determined by UV-spectroscopy, the purity of the [U-ribosyl-14C]AdoMet was verified by TLC, UV/Vis spectroscopy and HPLC against the authentic
material.

In vivo expression and purification of tRNATyr
E. coli K12QueA/pTRC99B-Tyr was grown in LB/amp medium at 37 °C. A glycerol
stock was used to inoculate 3 mL of LB/amp medium and the culture was left to grow for
12 hours, after which 1 mL was taken and used to inoculate 100 mL of LB/amp medium.
The 100 mL cultures were grown for 12 hours at 37 ºC with shaking at 250 rpm, 5 mL
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aliquots were taken from the 100 mL cultures and were used to inoculate 500 mL of
LB/amp medium. The cells in the 500 mL culture were grown for about 3 ½ hours until
an OD600 of about 0.9 was reached at which point the over-expression of tRNATyr was
induced by the addition of IPTG to a final concentration of 0.5 mM. The cultures were
allowed to grow for an additional 13 hours and were harvested by centrifugation at 5,000
x g for 15 minutes and frozen with liquid nitrogen. The cells were stored at -80 ºC until
further use. Approximately 50 g of cells were obtained from 7 L of LB.

The acid guanidium thiocyanate-phenol-chloroform method was used to lyse the cells
and extract the ribonucleic acids (68). Twenty grams of cells were suspended in 40 mL
of 4 M guanidium thiocyanate, 0.5% N-lauroylsarcosine, 100 mM βME and 25 mM
sodium citrate (pH 7.0). The cells were lysed by stirring at 4 ºC for 1 hour followed by
addition of 4 mL of 2 M sodium acetate (pH 4.0). The mixture was stirred for an
additional 5 minutes and 40 mL of water-saturated phenol was added. After shaking for
5 minutes, 8 mL of choloroform: isoamyl alcohol (49:1) were added and the solution
shaken vigorously for 10s. The aqueous phase was recovered after centrifugation at 800
x g for 20 minutes and the RNA was precipitated with the addition of an equal volume of
isopropanol followed by incubation at -20 ºC for 2 hours. The precipitate was collected
by centrifugation at 20,000 x g for 20 minutes and washed with 70% ethanol. The
enriched RNA was subjected to a second round of the acid guanidium thiocyanatephenol-chloroform extraction using a quarter of the original volumes to ensure complete
removal of the proteins.

After washing the RNA pellet with 70% ethanol and
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centrifuging, the pellet was dissolved in DEPC-treated water and an equal volume of 8 M
LiCl was added.

The solution was placed at -20 ºC for 2 hours, followed by

centrifugation at 20,000 x g for 20 minutes to remove the large RNAs. The supernatant
containing the tRNATyr was precipitated with isopropanol and washed with 70% ethanol
as previously described. The pellet was suspended in 3 mM sodium citrate pH 6.3. The
concentration of tRNATyr was estimated by UV-Vis spectroscopy ε260 = 861,000 L mol1

cm-1. Approximately 20% of the total RNA was determined to be tRNATyr by the tRNA

synthetase activity assays and QueA assay.

Purification of the tRNATyr
Crude tRNA (50 mg) was loaded on a 12 mL column (1cm ID) of BND cellulose in 20
mM NaOAc (pH 4.5), 10 mM MgCl2, and 0.5 M NaCl (69). A 100 mL linear salt
gradient 0.5 M to 1.0 M NaCl was applied followed by washing with 1 M NaCl until the
absorbance reading was below 0.25. A 40 mL ethanol gradient (0-20%) was applied for
the elution of tRNATyr. The volume of each fraction was 2 mL and the flow rate was 0.5
mL/minute. The presence of tRNATyr was assayed by the tRNA-tyrosine synthetase
assay and fractions which contained tRNATyr were pooled and the tRNA was precipitated
with isopropanol at 50% final concentration.

The tRNATyr was further purified by

continuous elution PAGE using BioRad 491 Prep Cell with 7 M Urea, 12% acrylamide
gel. The tRNATyr was prepared in 50% formamide (v/v), 10 mM EDTA, 0.1% (w/v)
xylene cyanol FF and 0.1% (w/v) bromophenol blue. The gel was run at 300 V, and 3
52

mL fractions were collected at a flow rate of 1 mL/min. The complete run took about 13
hours. To remove bound metal ions from the tRNATyr, it was washed with a 10 fold
volume of 3 mM sodium citrate followed by precipitation with isopropanol and cooling at
-20 ºC for 2 hours followed by centrifugation. The pellet was resuspended in 3 mM
sodium citrate (pH 6.3). The concentration of tRNATyr was determined by the tyrosinesynthetase assay and QueA assay and found to comprise greater than 70% of the isolated
tRNA.

In vitro transcription and purification of minihelix 17-mer
An

RNA

17-mer

representing

the

E.

coli

tRNAAsn

anticodon

stem-loop

(5’GCGGACUGUUAAUCCGC-3’) was synthesized in a reaction containing 40 mM
Tris-HCl (pH 8.0), 20 mM MgCl2, 1 mM spermidine, 50 µg/mL BSA, 2.5 mM DTT,
0.01% Triton X-100, 80 mg/mL polyethylene glycol, 0.5 µM of top and bottom DNA, 4
mM NTPs and 64 µg/mL T7-polymerase. The reaction was incubated at 37 ºC for 6
hours at which point the reaction was stopped by heating at 95 ºC for 3 minutes, followed
by centrifugation at 20,000 x g for 10 minutes. The 17-mer was precipitated by an equal
amount of isopropanol and cooling at -80 ºC for 2 hours.

The cold solution was

centrifuged at 20,000 x g at 4 °C 30 minutes. The pellet was washed with cold 70%
ethanol and placed at -20 ºC overnight. The solution was centrifuged at 20,000 x g for 30
minutes and the pellet was resuspended in 400 µL of 3 mM citrate (pH 6.3).
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The crude RNA was treated with RNase-free DNase (40 Units/mL of the in vitro
transcription) in 40 mM Tris-HCl (pH 8.0), 10 mM NaCl, 6 mM MgCl2 and 10 mM
CaCl2 for 30 minutes. The RNA oligomer was purified by continuous elution PAGE
using the BioRad 491 Prep Cell with a 7 M urea, 20% acrylamide gel in the following
manner: 10 mg of RNA in 80% formamide (v/v), 10 mM EDTA, 0.1% (w/v) xylene
cyanol FF, and 0.1% (w/v) bromophenol blue were loaded onto the gel and the sample
was electrophoresed at 200 V until the bromophenol blue was eluted, at which point
fraction collection began. Fractions (5 mL) were collected until xylene cyanol FF eluted.
The elution of the 17-mer was monitored on Urea/PAGE gels. The fractions containing
17-mer were pooled and concentrated by lyophilizing. The concentration of the RNA
was determined by UV/Vis spectroscopy with ε260 = 162,000 L mol-1 cm-1 and MW=
5442.4 Da.

Insertion of preQ1 into the minihelix RNA
The preQ1 base was inserted into the 17-mer in an E. coli TGT-catalyzed reaction. A 75
µg aliquot of TGT was added to a 1 mL solution containing 20 mM HEPES (pH 7.5), 10
mM MgCl2, 50 mM KCl, 2 mM DTT, 50 µM 17-mer and 300 µM preQ1. After 3 hours
at 37 ºC, the reaction was terminated by the addition of 0.1 volumes of 2 M NaOAc (pH
4.0) followed by one volume of water-saturated-phenol and 0.2 volumes of
chloroform:isoamyl alcohol (49:1). After vortexing for 20s, the solution was centrifuged
in a swinging bucket rotor at 700 x g for 20 minutes. The aqueous phase was recovered
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and applied directly to a Quick-Sep column containing 2 mL of Sephadex G-25. The
sample was centrifuged at 700 x g in a swinging bucket rotor for 1½ min to separate the
unreacted preQ1 from the 17-mer. The 17-mer in the eluate was precipitated by an equal
amount of isopropanol and cooling at -20 ºC overnight. The solution was centrifuged at
20,000 x g for 20 minutes and the RNA pellet was washed with 70% cold ethanol and
centrifuged again at 20,000 x g at 4 ºC. The 17-mer was resuspended in 3 mM citrate (pH
6.3) and stored at -80 ºC.

Determination of stereospecific abstraction of hydrogen by QueA
The conversion of preQ1 from either the 17-mer or tRNATyr was carried out under the
conditions of: 100 mM Gly-gly (pH 8.7), 100 mM EDTA (pH 8.7), 100 mM KCl, 50 µM
tRNA, 25 µM QueA and 1.0 mM of either (5’S)-[5’-2H]-AdoMet or (5’R)-[5’-2H]AdoMet. The reaction was left to run for 1 hour and terminated by heating for 3 minutes
at 95 ºC. The mixture was centrifuged at 20,000 x g in order to remove precipitated
protein, followed by separation of RNA from other reaction components by use of a spin
column with 500 µl G-25 sephadex. This process was performed twice and the collected
RNA was precipitated out by adding 0.1 volumes of 2 M NaOAc (pH 4.0) and one
volume of isopropanol and cooling at -20 ºC for 2 hours. The RNA was resuspended in
water to a final concentration of 1 µg/mL. The RNA digestion was carried out as
previously described (63). The RNA was denatured by heating at 100 ºC and rapidly
chilled in ice-water slush. One tenth volume of NH4OAc 0.1 M (pH 5.3), 5 µg of
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Nuclease P1 was added for 1 mg of RNA and the digestion was incubated at 42 ºC for 4
hours. This was followed by adding 0.1 volumes of freshly made 1 M NH4HCO3 (pH
7.8) and 0.05 U of phosphodiesterase the digestion was carried out for another 4 hours at
37 ºC. Lastly 20 Units of alkaline phosphatase were added and the dephosphorylation
was carried out for 2 hours at 37 ºC.

The oQ was purified on the HPLC by use of an analytical Gemini column (250 x 4.6 mm,
5 micron, Phenomenex), under gradient conditions of 100% 25 mM NH4OAc (pH 6.0) to
90% 25 mM NH4OAc/10% Acetonitrile at a flow rate of 1 mL/min over 30 min. The oQ
was collected, lyophilized and made up in 10 mM NH4OAc (pH 6.0)/50% methanol
followed by direct infusion analysis using a Thermo LCQ ion trap mass spectrometer.
The analysis was carried out in the positive mode. Proton NMR of the streospecifically
labeled AdoMet used in this analysis was carried out under acidic conditions with a pH of
approximately 3.0 in D2SO4.
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3. RESULTS

3.1 MjTgtA2
Identification, cloning, and purification of MjTgtA2
Using the gene clustering tool of the SEED database, the gene families that physically
clustered with tgtA, which encodes the archael TGT and encoded proteins with RNAbinding domains were identified as possible candidates for the enzyme involved in the
final transformation of preQ0-tRNA to G+-tRNA (Figure 16A). The tgtA2 family was
identified as a possible candidate, as members of this family cluster with tgtA genes in
phylogenetically distant archaea (Figure 16B). These genes had been previously
annotated as encoding TGT enzymes in most archaeal genomes because the
corresponding proteins present around 18% sequence identity with the canonical TGT
[the identity score was obtained from comparing the M. janaschii TGT (MJ0436) and
TgtA2 (MJ1022)]. Detailed analysis of the sequence alignments of the TGT and TgtA2
families revealed that, while the C2 and PUA domains were well conserved between the
two protein families, the N-terminal and C1 domains were not (70).

The major

differences in those two domains are the following: (a) the N-terminal domain in the
TgtA2 family is smaller than its counterpart in the TGT family by 70-130 N-terminal
residues, (b) active site and known catalytic residues in the N-terminal domain of TGT
are not conserved in TgtA2, (c) the C1 domain in TgtA2 is much larger than its
counterpart in TGT (200 residues in TgtA2, but only 40 in TGT) and (d) the C1 domain
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of TgtA2 contains a TgtA2-specific motif PC-X3-KPY-X2-S-X2-H (Figure 16C) not
found in TGT (70). The combination of the clustering evidence and the presence of a
PUA domain suggested that the tgtA2 gene family encoded an enzyme catalyzing one or
more steps in the conversion of preQ0-tRNA to G+- tRNA and was not a canonical TGT.

The mj1022 gene corresponding to tgtA2 gene in M. jannaschii was initially cloned from
genomic DNA via PCR and inserted into a pET32Xa/LIC vector to enable expression of
the recombinant protein as an N-terminal His6-Trx-fusion protein. The over-expression
of protein in E. coli BL21(DE3) was associated with low levels of recombinant protein
and production of truncated proteins. Sequence analysis of the mj1022 gene revealed that
it was highly A-T rich and contained numerous codons for lysine and arginine that are
rarely used in E. coli.

The expression profile was only marginally improved by

expression in Rosetta2 ™ cells, which are engineered to over-express a number of
specific tRNAs to compensate for the presence of rarely used codons in E. coli. In order
to improve protein expression, a codon-optimized synthetic gene was prepared for
expression in E. coli, and cloned via PCR into pET32Xa/LIC and pET30Xa/LIC
expression vectors harboring N- and C-terminal His6 fusion tags.

Expression from pVCIII-28 and pVCIV-42, which encode the N- and C-terminal His6
fusions, respectively, in E. coli BL21(DE3) was robust, and provided ~25 mg of
recombinant protein per liter of culture. However, purified protein obtained after Ni2+NTA agarose affinity chromatography was typically contaminated with one or more other
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polypeptides (Figure 17). In the case of the His6-Trx-fusion protein, several large bands
~15 KDa less than the fusion were observed, as well as a small band that was ~15 KDa,
while in the samples of C-terminal His6 fusion protein a single additional band ~7 KDa
smaller than the fusion was observed. When these samples were kept at temperatures
above freezing (4 °C to 25 °C) over a period of days to weeks, all of the fusion protein
converted to the smaller bands. Various protease inhibitors that were tested did not
prevent or influence the cleavage reaction, suggesting that the protein was undergoing
self-cleavage. The protein was prone to precipitation in different forms either as a fusion
or the cleaved product and required at least 0.5 M NaCl to remain in solution.

Determination of self-cleavage sites in N- and C-terminal fusions of MjTgtA2
To allow the N- and C-terminal recombinant fusion proteins to self-cleave, the Trx-His6MjTgtA2 and MjTgtA2-His6 fusion constructs were incubated at 4 °C for up to 4 weeks
and analyzed by Edman degradation.

N-terminal sequencing revealed that while

cleavage occurred in 2 specific regions, one within the fusion domain (Figure 18B) and a
second ~75 residues into the N-terminal domain of the native protein (Figure 18C), Nterminal heterogeneity was observed due to multiple cleavage sites within each region
(Table 1).
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Size exclusion chromatography
To evaluate the native molecular masses of His6-Trx-MjTgtA2 and cleaved MjTgtA2,
analytical size exclusion chromatography was carried out (Figure 19). A standard curve
was generated using carbonic anhydrase (29KDa), BSA (66 KDa), alcohol dehydrogenase (150 KDa), β-amylase (200 KDa), apoferritin (443 KDa) and thyroglobulin (669
KDa).

The His6-Trx-MjTgtA2 eluted with a calculated KD of 0.592.

For cleaved

MjTgtA2, the KD was 0.620. These were consistent with molecular weights of 154 kDa
and 122 kDa, and both masses were consistent with the formation of a dimer.

preQ0-tRNASer substrate preparation
Continuous PAGE was used to purify the tRNASer transcript (Figure 20) which was
composed of mainly two bands. The purified larger band was used for the subsequent
preQ0 incorporation reaction catalyzed by MjTGT. The lower band was assumed to be
the n-1 transcript product. The final product was pure as judged by PAGE (Figure 20).
In order to determine the amount of tRNASer that contained preQ0, MjTGT was initially
used to incorporate [8-14C]guanine into tRNASer.

The [8-14C]guanine previously

incorporated in tRNASer was then replaced by preQ0 in reaction catalyzed by MjTGT , and
essentially no radioactivity was detected after the preQ0 incorporation giving greater than
95 % preQ0-tRNASer.
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Glutaminase assays
The transformation of preQ0 to archaeosine suggested that the reaction could be catalyzed
by an amidotransferase.

Glutaminase activity was determined in the presence and

absence of ATP and preQ0-tRNASer. To probe for potential glutaminase activity that is a
characteristic trait of most amidotransferase enzymes, a coupled assay of MjTgtA2 with
glutamate dehydrogenase was used, and the reaction was followed by monitoring
NADPH production at 340 nm (Figure 21). [U-14C]-L-glutamate formation was also
monitored directly by using [U-14C]-L-glutamine. Glutamate formation in the MjTgtA2
assays, as deduced from glutamate dehydrogenase activity or from the direct production
of [U-14C]-L-glutamate, was dependent on MjTgtA2 (Figure 21 and 22) and did not
require ATP. Glutaminase activity was also determined in the presence of buffers other
than phosphate including, citrate, succinate, acetate, and HEPES. Glutaminase activity
was observed over a broad pH range (4.0 – 8.0) as shown in Figure 24, but was greatest
in HEPES buffer at pH 7.0 (Figure 25). Optimal glutaminase activity occurred at ~40 ˚C
and dropped off significantly above 45 ˚C (Figure 23). Based on radiochemical assays
for glutaminase activity, specific activities of 7.7, 11.4, and 16.3 µM/min/mg were
calculated for the self-cleaved protein, the full fusion protein, and the C-terminal tagged
protein, respectively.
In vitro amidotransferase activity of MjTgtA2
To determine if the glutaminase activity of MjTgtA2 was associated with an
amidotransferase activity and the formation of archaeosine, the ability of MjTgtA2 to
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catalyze archaeosine formation under various conditions was investigated. LC analysis
of the tRNA hydrolysates obtained from MjTgtA2 reactions carried out in the presence or
absence of ATP revealed a new peak with a retention time 17.9 min and a chromophore
(Figure 27A and 27C) that were distinct from that of preQ0 (17.1 min, Figure 27A and
B), but consistent with that of archaeosine (20). Subsequent LC-MS analysis of the
MjTgtA2-catalyzed reaction tRNA hydrolysates provided a parent ion (MH+ 325.1 m/z)
shown in Figure 28A consistent with archaeosine, as well as a significant daughter ion
(BH2+ 193 m/z) consistent with the archaeosine nucleobase. Archaeosine formation was
also observed when asparagine and NH4Cl were used in place of glutamine. Using [3H]asparagine, a specific activity of 3.23 µM/min/mg was calculated for asparaginase
activity with the fusion form of the enzyme in the absence of preQ0-tRNA (Figure 26).
Formation of G+ was also determined at various pH values; however unlike glutaminase
activity that was found to occur at acidic pH values, G+ formation was only observed at
pH 7 and above (Table 2).
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3.2 NADPH 7-cyano-7-deazaguanine oxidoreductase
Expression and purification of QueF proteins
Wild type QueF, C55A and E78A mutants were all expressed as fusion proteins from
pET30Xa-ykvm,

pET30Xa-ykvm-E78A

and

pET30Xa-ykvm-C55A

in

E.

coli

BL21(DE3) and purified by Ni2+-NTA agarose chromatography. The SDS-PAGE gel
showing QueF purification is shown in Figure 29. The proteins were all cleaved using
Factor Xa and the native proteins were obtained.

The cleaved fusion protein was

removed by a second round of purification on Ni2+-NTA agarose, where the cleaved tag
remained bound to the resin and the native protein was eluted in the absence of
imidazole. The QueF proteins were obtained to over 95% homogeneity as shown in
Figure 30.

Metal analysis
The effect of divalent metals on the activity of QueF was investigated. In order to
circumvent any potential time dependence on metal binding, the protein was preincubated
with the metal for at least 5 minutes before the reaction was initiated by the addition of
preQ0. The activity of the native proteins was determined in the presence of Mn2+, Cu2+,
Ca2+, Zn2+ and Mg2+ against a control of native QueF with EDTA (Figure 31). The
protein activity was observed to increase in the presence of divalent metals, however the
presence of EDTA was observed to result in a decrease in activity (Figure 31). At
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concentrations >1 mM for the Mn2+ and Ca2+ an inhibitory effect was observed, however
this was not observed in the presence of Mg2+. Increased protein activity was only
observed at low concentrations for Zn2+ and Cu2+ (10 µM), however at concentrations
>10 µM reduced activity was observed. Only Ca2+, Mg2+ and Mn2+ were used to further
determine their effect of QueF activity (Figure 32), all three metals were found to
increase the activity of the apparent apoprotein.

The effect of KCl on the activity of both the native and apparent apoprotein was
investigated, in the absence and presence of MnCl2. The activities of both the native and
apparent apoprotein were diminished in the presence of 100 mM KCl. However in the
presence of MnCl2, the activity of native QueF was found to be the same at both 50 mM
and 10 mM KCl, while the activity of the apoprotein was found to be greatest in the
presence of MnCl2 at 50 mM KCl. The effect of KCl is shown in Figure 33.

pH optima determination
The effect of pH on the activity of QueF was determined in MES (pH 5.5 - 6.67), TrisHCl (pH 6.8 -7.9), and potassium phosphate buffer (pH of 5.8 - 8.0). The optimal pH for
QueF activity was determined to be 6.5. All subsequent analyses were determined in the
presence of potassium phosphate pH 6.5 at 30 °C. The pH profiles are shown in Figure
34.

64

Size exclusion chromatography of QueF
The role of KCl, divalent metals, and the substrate preQ0 in the oligomeric structure of
QueF was evaluated by analytical size exclusion chromatography using a BioSep-Sec4000 column (Phenomenex) with a mobile phase of 25 mM phosphate (pH 7.2), 25 mM
KCl, at 1 ml/min. In experiments with preQ0 the enzyme and substrate were incubated
together for at least 10 minutes before the sample was injected for analysis, with the
preQ0 concentration present at two times the concentration of QueF.

The elution behavior of QueF in the absence of preQ0 and in the presence of a low salt
concentration (25 mM KCl) exhibited a broad, asymmetric peak with a retention time of
8.57 minutes (Figure 35A), corresponding to a MW of 200.7 kDa. The retention time of
QueF in the presence of preQ0 (i.e QueF-*PreQ0) shifted to 8.33 minutes (Figure 36A),
and while still exhibiting asymmetry the peak was sharper and narrower than in the
absence of preQ0. A smaller poorly defined peak was also observed to at an elution time
of 10.4 minutes, corresponding to a MW of 15.8 kDa close to the subunit MW of QueF
(19.4 kDa). Analysis of the absorption spectra for both peaks revealed the presence of a
distinct absorption at 376 nm (Figure 36 B and C) previously ascribed to the putative
thioimide intermediate.

The effect of KCl on the quaternary structure of QueF was investigated by observing the
elution behavior of the enzyme under different salt concentrations. The QueF protein
sample was initially incubated for 3 hours in the presence of 0.5 M KCl and 10 mM
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EDTA before analysis of the sample. At 0.5 M KCl the retention time of the apparent
multimeric state of the protein eluted later (8.78 minutes, Figure 35B) compared to 8.57
minutes (Figure 35A) observed in the absence of salt. Additionally a peak consistent
with a monomer was observed to elute with a retention time of 10.4 minutes (Figure
35B). The presence of an excess of either of the divalent metals Mg2+ or Mn2+ appeared
to have no effect on quaternary structure as the retention times (data not shown) of QueF
in the presence of the these ions were identical to that of QueF alone.

QueF Crystal structure
Crystal structures of QueF were determined in collaboration with Dr. Manal A. Swairjo
(Western University of Medicine). Crystal structures of QueF at 2.5 Å and 2.25 Å
resolution where solved for the covalent binary complex of QueF with preQ0 trapped in
the thioimide intermediate state, and of a non-covalent ternary complex with preQ0 and a
cofactor surrogate, respectively.

The overall enzyme structure in both reveals an

asymmetric tunnel-fold homodecamer of two head-to-head facing pentameric subunits
possessing the characteristic architecture of unimodular pterin and purine binding
enzymes (Figure 37). Each of the ten active sites in the QueF homodecamer lie at the
interface between three subunits, two from one beta barrel and one from the opposite beta
barrel. The active site is comprised of the substrate and cofactor binding pockets. The
preQ0 binding pocket is defined by a cleft between the two subunits from the same beta
barrel. PreQ0 forms hydrogen bonds via its N1 and N2 atoms with the invariant Glu97
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side chain, and via its N9 atom with the side chain of Glu79 (the first residue in the
conserved QueF motif). The substrate binding pocket is also lined with hydrophobic
residues that make Van der Waals interactions with preQ0. PreQ0 is bound in eight of ten
active sites, and forms a thioimide covalent linkage with the conserved catalytic residue
Cys55, consistent with previous biochemical evidence. The pentameric substructure of
QueF is shown in Figure 38; the subunit without the thioimide is present in a different
conformation when compared to the subunits with thioimide. Figure 39 shows the first
structural evidence of the thioimide formed in the QueF active site. The crystal structure
of the QueF-PreQ0 thioimide intermediate complex clearly shows that the Cys55 sulfur
atom forms a 1.87 Å covalent bond with the preQ0 nitrile carbon atom.

The

conformational changes seen in the active site upon thioimide formation are rotations in
the side chains of Cys55 and Asp62.

Glucosamine originating from dextran sulfate, which was included as an additive in the
crystallization buffer, is observed in the adjacent active site to the preQ0 binding site
(Figure 40). This ligand apparently acts a as surrogate of the enzyme cofactor NADPH
and occupy the putative NADPH site predicted previously using modeling tools. The
cofactor pocket is at the interface between three subunits and involves residues from all
three. The QueF motifs from two subunits contribute side chains to the cofactor binding
site.
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QueF fluorescence assays
The tryptophan residue` has been used extensively in the determination of ligand and
protein interactions. Since QueF has a single tryptophan residue at position 119, the
fluorescence of QueF in the presence and absence of preQ0 was measured in order to
study QueF and preQ0 interactions. When tryptophan was excited at 295 nm, QueF was
found to have an emission maximum at 334 nm while the emission maximum of
quenched QueF-PreQ0 complex was observed to shift to 328 nm (Figure 41A). The
optimal emission for NADPH was also determined under the reaction conditions to be at
465 nm (Figure 41B) when excited at 340 nm.

Transient state kinetics data analysis
For data analysis with Dynafit, a model for the reaction taking place was put forth for
different reactions in order for the program to calculate the rate constants for the various
steps in the QueF-catalyzed reaction of reduction preQ0 to preQ1.

The fitting function (model equation) for each individual data set is
S(t) = S0 + ∑ni=1 ri ci(t)
where
S(t)

the experimental signal observed at time t

S0

offset on the signal axis (a property of the instrument)
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n

number of unique molecular species participating in the reaction mechanism

ci(t)

the concentration of the ith species at time t

ri

the molar response coefficient of the ith species

The molecular species participating in the mechanism are defined for each of the various
reactions. The concentrations of these molecular species at time t are computed from
their initial concentrations (at time zero, t = 0) by solving an initial-value problem
defined by a system of simultaneous first-order Ordinary Differential Equations (ODEs)
listed for each of the reactions below.

Fluorescence measurements of preQ0 binding to QueF C55A
In order to investigate the binding of preQ0 to QueF in the absence of thioimide
formation the kinetics of preQ0 binding were first determined with the C55A mutant of
QueF, which is incapable of reacting to form the thioimide. Binding was monitored by
measuring the change in the intrinsic tryptophan fluorescence under pre-steady state
conditions. The proposed model for binding of QueF (C55A) and preQ0:

kas
QueF +

PreQ0

kds

Ordinary Differential Equations
Where S = PreQ0 and E= QueF
d[E]/dt

=

- kas[E][S] + kds[ES]
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.

QueF PreQ0

d[S]/dt

=

- kas[E][S] + kds[ES]

d[ES]/dt

=

+ kas[E][S] - kds[ES]

When binding was initially investigated at 30 ˚C, the normal assay temperature for QueF,
the binding was too fast to be measured accurately in the millisecond time regime, so the
temperature was lowered to 20 ˚C. Under these conditions binding was clearly observable
and the data were nicely fit with a single exponential, the association constant from
global analysis of the data (Figure 42A); was calculated to be 1.06 ± 0.31 µM-1s-1, with a
dissociation constant of 1.35 ± 0.26 s-1.

Fluorescence measurements of preQ0 binding to wild type QueF

In order to investigate preQ0 binding and thioimide formation, fluorescence measurements were conducted on wild-type QueF. Previous experiments demonstrated that the
thioimide intermediate was stable over several hours (71), and therefore the breakdown
of the covalent adduct was assumed to be negligible in evaluating kinetic data under presteady state conditions. The proposed model for preQ0 binding and thioimide formation
in wild type QueF thus was the following:

QueF +

PreQ0

kas

.

QueF PreQ0

kds

.

QueF PreQ0

kr
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QueF-*PreQ0

Ordinary Differential Equations
Where E = QueF, S = PreQ0, E-S = QueF-*PreQ0 (QueF with thioimide)
d[E]/dt

= -kas[E][S] + kds[E.S]

d[S]/dt

= -kas[E][S] + kds[E.S]

d[E.S]/dt

= +kas[E][S] - kds[E.S] - kr[E.S]

d[E-S]/dt

= + kr[E.S]

Experiments were again carried out at 20 ˚C, but in this case the data was biphasic and
was only adequately fit by a double exponential. The association constant from global
analysis of the data was calculated to be 1.32 ± 0.26 µM-1s-1, identical within
experimental error to the value calculated with the C55A mutant, while the dissociation
constant was found to be 7.95 ± 1.52 s-1, roughly 8-fold larger than in the mutant. The
rate of thioimide formation was found to be 1.30 ± 0.05 s-1.

Absorbance measurements of thioimide formation in QueF under pre-steady state
conditions
The kinetics of thioimide formation were also investigated by directly observing the
appearance of the thioimide absorbance band at 370 nm. When the data were fit to a twostep mechanism comprising preQ0 binding followed by thioimide formation, identical to
that utilized in the fluorescence experience, the residuals were clearly non-random
(Figure 44C). In this case the data was better fit by a mechanism incorporating another
step prior to the formation of the thioimide, such as an isomerization step or a shift in the
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equilibrium of a heterogeneous population of QueF to give the reactive form of the
protein upon mixing with the preQ0. The proposed model for reaction of QueF with
preQ0 is shown below:
kef
F

+

F

QueF
kfe
kas

QueF + PreQ0

.

QueF PreQ0

.

QueF PreQ0

kds
kr

QueF-*PreQ0

Ordinary Differential Equations
Where F = pentamer, E = QueF= decamer
d[F]/dt

= - kef[F][F] - kef[F][F] + kfe[E] + kfe[E]

d[E]/dt

= + kef[F][F] - kfe[E] - kas[E][S] + kds[ES]

d[S]/dt

= - kas[E][S] + kds[ES]

d[ES]/dt

= + kas[E][S] - kds[ES] - kr[ES]

d[E-P]/dt

= + kr[ES]

Using this model global analysis of the data (Figure 44A and B) provided a rate for
thioimide formation of 2.55 ± 0.014 s-1 at 30 ˚C, in close agreement to the value calculated above from the fluorescence experiments carried out at 20 ˚C.
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Fluorescence measurements of NADPH binding to the E78A mutant QueF-*PreQ0
under transient state kinetics
Proposed model for NADPH binding to E78A QueF-*PreQ0 :
kas
QueF-*PreQ0 + NADPH

.

QueF-*PreQ0 NADPH
kds

.

QueF-*PreQ0 NADPH

k1
k-1

.

F-*PreQ0 NADPH

Ordinary Differential Equations
where E-S = QueF-*PreQ0, and F-*PreQ0 is a different state of the protein possibly after
isomerization
d[E-S]/dt

= - kas[E-S][NADPH] + kds[E-S.NADPH]

d[NADPH]/dt

= - kas[E-S][NADPH] + kds[E-S.NADPH]

d[E-S.NADPH]/dt= + kas[E-S][NADPH] - kds[E-S.NADPH]
-k1[E-S.NADPH] + k-1[FS.NADPH]
d[FS.NADPH]/dt = + k1[E-S.NADPH] - k-1[FS.NADPH]

The association constant from the Dynafit and KaleidaGraph analysis was found to be 0.2
± 0.01 µM-1 s-1 and the dissociation constant was found to be 0.24 ± 0.06 s-1 , the
isomerization constants of the protein after binding of NADPH were calculated to be k1 =
1.18 ± 0.04 s-1 and k-1 = 0.12 ± 0.02 s-1at 20 oC. The global analysis (Figure 45 C) and an
example of residuals for the fit are shown in Figure 45 D, while the biphasic nature of the
data is clearly shown by the Kaleidagraph fits for single and double exponential decay in
Figure 45 A and B.
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Fluorescence measurements of NADPH binding and thioimide reduction under
single turnover conditions

The proposed model for NADPH binding and thioimide reduction in wild type QueF*PreQ0 under single turnover conditions is shown below. NADPH fluorescence was
monitored.
kas
QueF-*PreQ0

+ NADPH
kds

.

QueF-*PreQ0 NADPH

.

QueF-*PreQ0 NADPH

kr

.

QueF=*PreQ0 NADP+

Ordinary Differential Equations
d[E-S]/dt = - kas[E-S][NADPH] + kds[E-S.NADPH]
d[NADPH]/dt = - kas[E-S][NADPH] + kds[E-S.NADPH]
d[E-S.NADPH]/dt = + kas[E-S][NADPH] - kds[E-S.NADPH] - kr[E-S.NADPH]
d[E=S.NADP+]/dt = + kr[E-S.NADPH]
The association constant (kas) from the Dynafit and KaleidaGraph analysis was found to
be 0.06 ± 0.0007 µM s-1 and the dissociation constant (kds) was found to be 0.2 ± 0.03 s-1
while the rate of reduction (kr) was calculated to be 0.12 ± 0.01 s-1at 20 oC. The global
analysis and an example of residuals for the fit are shown in Figure 46A and B.
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Absorbance measurements of thioimide reduction monitored at 390 nm
Thioimide reduction was also determined directly by monitoring the thioimide
absorbance. In order to avoid the overlap in the NADPH and thioimide absorptions
(Figure 47), the reaction was monitored at 390 nm. The proposed model for NADPH
binding and thioimide reduction in wild type QueF-*PreQ0 under single turnover
conditions is shown below.
kas
QueF-*PreQ0

+ NADPH

.

QueF-*PreQ0 NADPH
kds
kr

.

QueF-*PreQ0 NADPH

.

QueF=*PreQ0 NADP+

Ordinary Differential Equations
d[E-S]/dt

= - kas[E-S][NADPH] + kds[E-S.NADPH]

d[NADPH]/dt

= - kas[E-S][NADPH] + kds[E-S.NADPH]

d[E-S.NADPH]/dt

= + kas[E-S][NADPH] - kds[E-S.NADPH] - kr[E-S.NADPH]

d[E-S.*NADP]/dt

= + kr[E-S.NADPH]

The kas (0.06 µM s-1) and kds (0.2 s-1) used in this analysis were determined in the
experiment monitoring NADPH fluorescence. The rate of reduction (kr) was calculated
to be 0.24 ± 0.0007 s-1at 30 oC the global analysis and an example of residuals for the fit
are shown in Figure 48.
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Absorbance measurements of thioimide decomposition
Thioimide decomposition was monitored at 370 nm and data was collected on the Carey
100 spectrophotometer. The proposed mechanism is shown below;

QueF-*PreQ0

kr

QueF + PreQ0

Ordinary Differential Equations
Where A = QueF-*PreQ0, E = QueF and S = PreQ0
d[A]/dt

=

- kr[A]

d[E]/dt

=

+ kr[A]

d[S]/dt

=

+ kr[A]

The rate of thioimide decomposition (kr) was calculated to be 4.81 ± 0.02 E-6 s-1at 30 oC
the fitted data is shown in Figure 49.
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3.3 S-Adenosylribosylmethionine:tRNA ribosyl transferase isomerase
Stereospecific abstraction of the C5’ proton by QueA
To investigate if the proton abstraction by QueA was stereospecific, stereospecifically
labeled deuterium AdoMet was used. PreQ1-tRNA that had been converted to oQ-tRNA
was digested as previously described (63). The proton NMR of the AdoMet used in the
determination of stereospecific abstraction of the C5’ proton by QueA is shown in Figure
53. The proR proton is at the chemical shift of δ 4.05 in the unlabeled AdoMet while the
proS proton is at the chemical shift of δ 3.919.

Chromatograms showing the products of these digestions are shown in Figure 51, preQ1
had a retention time of 17 minutes while oQ had a retention time of 22.5 minutes. The
oQ was collected from HPLC purification, oQ samples generated from 5’S-[5-D]AdoMet, 5’ R-[5-D]-AdoMet, and unlabeled AdoMet were all lyophilized and analyzed
by mass spectrometry. The results of these analyses are shown in Figure 52. The data
obtained indicate that QueA removes the 5’S proton of AdoMet.
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4. DISCUSSION

4.1 Archaeosine synthase
Archaeosine is a modified nucleoside that has been found in most archaeal tRNAs
analyzed to date. However, until recently its biosynthesis was poorly characterized.
Early biosynthesis studies on queuosine and structurally related metabolites led to the
proposal that GTP was a metabolic precursor to archaeosine (37). Even though TGT, the
enzyme that catalyzes the insertion of preQ0 into tRNA was identified and characterized a
decade ago (55, 72), candidate(s) for the transformation of preQ0-tRNA to archaeosinetRNA were yet to be identified and characterized. The goal of this work was to test the
hypothesis that the TgtA2 enzyme catalyzes the formation of archaeosine from preQ0 in
tRNA.

Comparative genomic analysis and in vivo studies were conducted to determine the
participation of M. jannaschii TgtA2 (MjTgtA2) in archaeosine biosynthesis. H. volcanii
was chosen to investigate the in vivo function of tgtA2. A ∆tgtA2 mutant was constructed
in H. volcanii and LC-MS analysis on the tRNA hydrolysates indicated that no
archaeosine was present in the mutant strain, suggesting that the tgtA2 gene encoded a
protein involved in the biosynthesis of archaeosine. To test this hypothesis, the tgtA2
gene from M. jannaschii was cloned and the encoded protein, MjTgtA2, was expressed
and purified.
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The expression and purification of MjTgtA2 proved to be challenging as initial attempts
to express from its native gene resulted in low levels of expression as well as truncated
protein.

A codon-optimized gene was constructed in order to improve expression;

however truncated protein was still obtained. Slowing down transcription by lowering
expression temperature as well as lowering the final IPTG concentration did not improve
the protein expression. MjTgtA2 was cloned in several vectors in order to improve both
formation of full length protein as well as formation of soluble functional protein, but
only the expression of soluble protein was improved. In order to determine if the protein
was being truncated due to the activity of proteases from E. coli, a protease inhibitor
cocktail as well as EDTA were added during protein purification, but truncated protein
was still obtained. Expression of MjTgtA2 as a C-terminally tagged protein resulted in
purification of full length protein. This suggested that the truncated protein obtained
during the purification was not due to protease activity from endogenous E. coli proteins
but most likely due to a characteristic of MjTgtA2. If the proteolysis observed was due to
E. coli proteases the C-terminally tagged protein would have shown the same degree of
cleavage observed in the N-terminally tagged protein. Due to observed loss in activity of
MjTgtA2 when stored at low temperatures (e.g - 20 °C), the protein was stored at 4 °C.
However, SDS-PAGE analysis of the C-terminal His6- MjTgtA2 indicated the presence
of a lower protein band that was absent when the protein was initially purified (Figure
18). SDS-PAGE analysis of the Trx-His6- MjTgtA2 also revealed that after incubation of
the protein for several weeks at 4 °C all the protein was truncated to fragments of lower
molecular weight (Figure 18).
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Together, these results suggested that the protein was undergoing self cleavage. Edman
degradation was used to determine the N-terminal sequences of the bands.

The

sequencing results indicated that proteolysis occurred in two regions in the protein, but
did not appear to be highly specific. Close analysis of the data obtained after sequencing
did not reveal any particular sequence characteristics that might be required for self
cleavage to take place. It was interesting to note that the self cleavage in the protein
appeared to occur quite readily during the purification in all the N-terminally tagged
proteins, but when the recombinant protein was left to incubate at 4 °C the cleavage of
the protein was very slow. In order to determine if the choice of purification resin (Ni2+NTA agarose) was somehow catalyzing the cleavage reaction, the Trx-His6- MjTgtA2
was incubated with several divalent metals (data not shown) and the proteins were
monitored for several weeks. However, no apparent increase in cleavage of the protein
was noted when the samples incubated with divalent metals were compared to the sample
with no additional divalent metal, suggesting that the Ni2+ or divalent metals did not
influence the rate of cleavage. The significance of self cleavage that was observed in the
heterologously expressed protein remains unclear. It was also not clear whether self
cleavage would occur when the protein is expressed in its native environment.

Analytical gel filtration analysis of full length and purified self cleaved protein revealed
that MjTgtA2 formed dimers in solution. Interestingly TGT has also been observed to
form dimers (73).
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Analysis of the possible chemistry in the transformation of a nitrile group to a
formamidine group in tRNA resulted in a proposal of two possible routes (Figure 54).
The first involved nitrile hydratase activity, to yield 7-amido-7-deazaguanosine, which
could then be converted to archaeosine in a canonical amidotransferase catalyzed
reaction. This route had precedence in a known nitrile hydratase from Streptomyces that
hydrolyzes the nitrile of the structurally similar toyocamycin (7-cyano-7-deazaadenosine)
to the amide sangivamycin (74, 75) and many well characterized amidotransferases.
Alternatively, the formal addition of ammonia to the nitrile of preQ0 can generate
archaeosine directly, representing a unique class of amidotransferase chemistry as well as
the only example of the conversion of a nitrile to a formamidine known in biology.

Given the precedence of glutamine as the ammonia donor in amidotransferase reactions
the activity was initially monitored in a coupled reaction to glutamine dehydrogenase in
order to determine if any glutamate was being formed by observing the formation of
NADPH. NADPH formation was observed, providing the first evidence that MjTgtA2
was capable of glutaminase activity. Glutamate formation was also observed when [U14

C]-L-glutamine was used and the assays were monitored by TLC. The temperature

dependence of glutaminase activity was investigated, and activity was observed to drop
significantly at temperatures above 40 °C, which was surprising given that this protein is
from a thermophile whose optimal growth temperature is approximately 85 °C (76).
Enzymes from thermophiles typically exhibit low activity at ambient temperatures where
the mesophilic enzymes exhibiting similar function are optimally active (77).
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Additionally MjTGT, which catalyzes the preceding reaction, had already been shown to
exhibit maximal activity at 80 °C (72).

The thermal stability of the protein was

investigated by heating the protein for 15 minutes at different temperatures from 50 °C to
80 °C. Over 80% of the protein was found to stay in solution even when heated at 80 °C
suggesting that the loss in activity at higher temperatures was not due to the protein
precipitating out of solution at high temperatures. Given the comparable glutaminase
activity observed in the presence and absence of tRNA, it is likely that the assay
conditions are not optimal, and this might explain the temperature sensitivity of the
enzyme activity.

Notably, MjTgtA2 was observed to utilize asparagine as well as glutamine as an
ammonia donor, with glutaminase activity being ~4 fold higher than asparaginase
activity.

The glutaminase activity was determined in different buffers and varying pHs and it was
observed that optimal glutaminase activity was found to occur in HEPES buffer (pH 7.0),
but archaeosine formation was only found to occur at pH's greater than 7. Archaeosine
was also formed when either asparagine or NH3 was the substrate, however NH3dependent activity was optimal at higher pH, similar to what has been observed in other
amidotransferases such as E. coli imidazole glycerol phosphate synthase (78). Under
basic pH conditions there is a higher concentration of NH3 from NH4Cl, which might
explain why G+ formation was only observed at basic pH.
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Most glutamine

amidotransferases have been found to be capable of substituting glutamine with NH3 (79,
80). However the formation of G+ in the presence of asparagine was surprising as only
tRNA-dependent amidotransferases GatCAB and GatDE (81) have been shown to be able
to use both glutamine and asparagine as nitrogen donors.

Sequence and structural comparisons of MjTgtA2 with other amidotransferases exhibited
no sequence or structural homology to either the class I, class II or GatCAB/DE enzymes,
suggesting that the amidotransferase activity of TgtA2 evolved separately from all other
known amidotransferase enzymes. However a search for similar structures to the C1
domain of MjTgtA2 resulted in multiple hits. An intriguing similarity was found to
Pseudomonas

glutaminase-asparaginase,

which

glutamine/asparagine to glutamate/aspartate.

catalyzes

the

hydrolysis

of

The similarity of MjTgtA2 to the

Pseudomonas glutaminase-asparaginase might explain MjTgtA2's ability to use both
asparagine and glutamine as nitrogen donors.

The biochemical analysis carried out on MjTgtA2 activity provides the first clear
demonstration that the enzyme catalyzing the ultimate step in archaeosine biosynthesis is
an amidotransferase that utilizes novel chemistry to achieve the transformation of a cyano
group to a formamidine.
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4.2 QueF
QueF catalyzes the NADPH-dependent reduction of 7-cyano-7-deazaguanine (preQ0) to
7-aminomethyl-7-deazaguanine (preQ1), a late step in the queuosine pathway (47). QueF
exhibits sequence homology to the type I GTP cyclohydrolases (GTP-CH-I) exemplified
by E. coli FolE. The homology between two protein families (Figure 55) resulted in an
initial misannotation of QueF activity, however it was also used to predict that the two
protein families belong to the same structural family, tunneling-fold structural family (47,
56).

The discovery of QueF activity added a novel type of chemistry in the

biotransformation of a cyano group to an amine, a common reaction in organic chemistry
but which had never been observed in nature. The activity of QueF places it in a class of
enzymes

traditionally

known

as

NAD(P)+-dependent

four-electron-transfer

dehydrogenases (82). Interestingly, these enzymes lack sequence homology and also
employ distinctly different chemical mechanisms (71), but ultimately result in the 4electron reduction or oxidation of their substrate.

The similarity between B. subtilis QueF and GTP-CH-I in sequence and multimeric
quaternary structure resulted in a prediction that the active site of B. subtilis QueF would
be in a similar location, i.e. at the intersubunit interface (56). Based on the crystal
structure of E. coli GTP-CH-I, a three-dimensional homology model QueF was built with
a preQ0 molecule was docked in the putative active site (Figure 56). In one monomer, the
preQ0 interacts with the two invariant of Glu97 and Cys55, the two interactions are also
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found in the structure of the GTP-CH-I-GTP complex. Mechanistic studies previously
carried out in our lab clearly demonstrated that (Cys55) (B. subtilis numbering) was
involved in the formation of a covalent thioimide intermediate via reaction with preQ0
(71), a mechanism for the reaction catalyzed by QueF was proposed based on the
presence of a covalent intermediate (Figure 57). The role of Glu97 was also investigated,
a conserved residue in the QueF family (Figure 55).

Based on its position in the

homology model Glu97 was implicated to play a role in anchoring bound preQ0 in the
active site, similar to other T-fold proteins. Steady state kinetic analysis of QueF Glu97
mutants showed that the relative specific activity to wild type activity was in the range of
1-6%, suggesting that Glu97 might play the predicted role of positioning preQ0 the active
site of QueF as in other T-fold proteins (57).

Isotope labeling studies with

stereospecifically deuterium labeled NADPH were utilized to determine the
stereospecificity of the hydride transfer reaction catalyzed by QueF, demonstrating that
the hydride transfer was pro-R specific.

Steady state kinetic isotope measurements

indicated a primary isotope effect (kH/kD) of 2.59, suggesting that the chemical step of
bond breaking of C-H in NADPH, transfer of the hydride and formation of the new C-H
bond is at least partially rate-determining on the overall kcat of the reaction.

The goal of this work was the transient state kinetic analysis of substrate binding and
catalysis by QueF as well as the investigation of ligand effects on the quaternary
structure. Determination of the elementary rate constants allows the identification of the
reaction(s) that limit the activity of QueF.
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Data from steady state kinetic analysis

provides indirect information to define the pathway; however, because kcat and km are
complex functions of individual rate constants, the individual reactions steps cannot be
resolved under steady state conditions. Transient kinetic methods allow examination of
the reaction pathway where the enzyme is examined as a stochioimetric reactant,
allowing individual steps in the pathway to be determined by direct measurement. Single
turnover experiments, which were utilized in elucidation of some of the rate constants,
were performed under conditions in which the concentration of the enzyme is in excess of
that of substrate. These conditions ensure that a single enzymatic turnover of the active
site can be measured directly without the concern that the substrate binding or product
release step is rate limiting.

Our proposed minimal kinetic mechanism for QueF is shown in Figure 9 a Bi-Uni-UniBi-Ter-Ter Ping Pong kinetic mechanism. PreQ0 binding was determined in the wild
type QueF as well as in the C55A mutant by monitoring the changes in the tryptophan
fluorescence. Thioimide formation was monitored at 370 nm under single turnover
conditions. For the data analysis we proposed a model based on previously established
stability of the thioimide (71), which was found to be still present after several hours after
dialysis.

This knowledge simplified the kinetics for preQ0 binding and subsequent

thioimide formation, as the thioimide decomposition step was taken to be essentially
irreversible on the time scale for pre-steady state kinetics. The binding of preQ0 to QueF
was initially determined and values found from this analysis were constrained in the
calculation of thioimide formation rates.
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In order to isolate the step(s) for NADPH binding and catalysis from preQ0 binding and
thioimide formation, a preformed QueF-*PreQ0 complex for either the wild type or
mutant E78A was used. The first eight proposed rates (k1, k-1, k2, k-2, k3, k4, k-4) were
directly measured in either absorbance or fluorescence based stopped flow experiments.
We also attempted to measure the kinetics of NADP+ binding to QueF-*PreQ0 using
fluorescence. Unfortunately the results were difficult to interpret because the quenching
of the tryptophan fluorescence in the presence of the thioimide is so large that it obscured
any possible changes due to NADP+ binding, such that nothing conclusive was obtained
from these experiments.

Multiple turnover kinetics were carried out in order to investigate the rate of catalysis for
the second hydride transfer.

From the multiple turnover analysis, only NADP+

dissociation and the second hydride transfer were calculated. The thioimide covalent
intermediate was used in the analysis such that the preQ0 binding was excluded from the
equations defining the reaction observed. NADPH binding previously determined was
held constant and also assumed to be unchanged for two reduction cycles. An enzyme
isomerization step was proposed to occur after the binding of the second equivalent of
NADPH; values calculated from the E78A proposed isomerization were used in the
fitting. In the end only the NADP+ dissociation and second reduction were calculated;
these steps were proposed to be irreversible under the conditions of the experiment as
attempts to determine rates of the reverse reactions resulted in values with very high
coefficients of variation making it highly unlikely that the reverse reactions for these two
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steps were significant under the experimental conditions. The results from the kinetic
analysis indicate that the binding of preQ0 and NADPH to QueF, as well as thioimide
formation, are very rapid; and that reduction of the thioimide is most likely the rate
limiting step. Analysis of component rates suggests structural changes occur between
these steps, further limiting the overall rate.

The structure of QueF was recently solved providing crystallographic evidence of the
formation of the thioimide between Cys55 and preQ0. Surprisingly, the crystal structure
also revealed the presence of Mg2+ ions at the subunit interface between the two
pentamers. Previously, activity analysis with divalent metals suggested that they did not
have any effect on enzyme activity. However the presence of the Mg2+ in the crystal
structure led to further investigation of a possible role of divalent metals in QueF
assembly and activity. The activities of the native enzyme and its apparent apoprotein
were determined in the presence of divalent metals as well as in the presence of EDTA.
The presence of divalent metals was shown to increase QueF activity while addition of
EDTA resulted in a decrease of QueF activity. The effect of KCl was also determined,
and concentrations greater than 100 mM were found to inhibit activity as previously
shown (71). The effect of divalent metals on the activity of the protein suggested that, as
observed in the crystal structure, the presence of a divalent metal is important to maintain
the quaternary structure of QueF. Given the positions of the Mg2+ ions it seems unlikely
that the divalent metal plays a direct role in catalysis. The QueF "apparent apoprotein"
was found to have lower activity than native protein. The activity observed for the
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apparent apoprotein could be due to tightly bound metal that was not removed by the
demetallating process; however this was not confirmed. It could also imply that the
presence of the metal is not essential for quaternary structure, but that it helps to stabilize
the quaternary structure allowing the reaction to take place more readily. The inhibitory
effect observed by KCl at high concentrations might indicate some disruption of the
quaternary structure. This is consistent with the observation that this effect is greatly
attenuated when the reaction is carried out in the presence of divalent metals.

In order to further investigate the effects of the metals on the QueF structure, analytical
size exclusion chromatography was carried out. One of the greatest limitations of size
exclusion chromatography is that resolution of the emerging peaks is limited (83). Gel
filtration is a relative technique, requiring calibration using molecular weight standards.
However, when a heterogeneous system is analyzed it is not always possible to resolve
intermediates that are present in the population being analyzed. Size exclusion analysis
of a multimeric protein such as QueF is complicated by the increased probability that
multimers of the subunits might be present in different multiplicities. Close analysis of
Figure 35A reveals an asymmetrical peak, which is characteristic of a heterogeneous
population where a sharp leading edge and an extended trailing edge is expected for
rapidly equilibrating species (84). A system in rapid equilibrium between two or more
states cannot be resolved into the different species present in the population if the rate of
exchange of the conformers is much faster than the characteristic time of the
chromatography. However, when the transition between the different conformations is
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sufficiently slower than the time of analysis, it is possible to show the presence of more
than a single peak in a chromatographic run. The peak for QueF alone was observed to
be broad, particularly when compared to the one obtained when QueF was preincubated
with preQ0, i.e. QueF with thioimide present. The elution of QueF-*PreQ0 earlier than
QueF alone suggests that there is either a change in the conformation of the protein when
the thioimide is made or that there is a shift in the equilibrium of the QueF population.
As gel filtration is a technique that is based on correlation of the measured retention time
and Stokes radius of a protein (85), any change in conformation that changes the radius
would also affect the retention time. Close analysis of the QueF-*PreQ0 (Figure 36A)
peak (8.33 min) reveals that while it is narrower than in the absence of preQ0 it possesses
a shoulder, suggesting that though the equilibrium is shifted towards the decamer, there is
still a small fraction of the population that exists as a pentamer. Interestingly, a less
pronounced peak was also observed eluting at about 10.4 minutes. The retention time
and UV spectrum of this peak (Figure 36C) is consistent with the presence of a QueF
monomer that has the thioimide present. Given that the monomer was clearly resolved
from the multimeric peak it suggests that upon injection a fraction of the population was
already present as monomer units. Attempts to collect the decamer QueF-*PreQ0 peak
and reinject it to determine if the monomer was originating from dissociation of the
decamer were inconclusive as a broad peak was observed, suggesting a requilibration of
the system between the decamer and pentamer states. The monomer subunit observed
might also be due to possible equilibrium between monomers and the multimeric
complexes, such that even if the monomer is unable to form the thioimide on its own, the
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existing equilibrium between the monomers and multimers result in part of the monomer
population having a thioimide present. The two possible pathways for formation of the
thioimide found in the monomer cannot be distinguished by gel filtration.

When a QueF sample was exposed to 0.5 M KCl in the absence either Mg2+ or Mn2+ ions,
the protein was found to fall apart readily but a fraction of the population remained intact
to give the decamer peak (data not shown). However, when QueF previously equilibrated with Mg2+ was incubated in the presence of 0.5 M KCl and 10 mM EDTA, it resulted
in two distinct peaks, a peak for the multimeric protein, which eluted later than when the
analysis was carried out in the presence of low salt, and a peak corresponding to the
monomer subunit. The elution of the peak corresponding to the multimeric protein at a
later time is an indication that at high KCl concentrations, the equilibrium is shifted
towards the pentameric state of the protein from the decamer. The mass of this peak was
calculated to be approximately 150 kDa, which is an average of the masses of the
pentamer and decamer oligomers. The presence of a clear peak for the monomer unit
shows that a significant amount of protein is dissociated and suggests that the equilibrium
between the monomer and multimeric forms of the protein is slow, as it is possible to
separate the different populations on the time scale of the experiment, which would not
be the case if there was a rapid exchange. These results suggest that the QueF population
is not uniform and that there is a dynamic equilibrium between different forms of the
protein.

The binding of small inorganic ions has been shown to cause protein
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dissociation in other systems, such as the dissociation of tryptophanase in the presence of
monovalent cations (86).

Two types of associations are found in macromolecules, static and dynamic. Static
associations are slow, making it possible to distinguish the different states that constitute
the population (87). Dynamic associations occur very rapidly (87) and it is not possible
to separate the various components of the population, such that an average is observed,
which appears to be what we see in gel filtration analysis of QueF.

Analytical

ultracentrifugation and the technique of sedimentation equilibrium can be used to
determine the native molecular weight of oligomeric proteins as well as in the
investigation of interacting systems, and is the method of choice in analyzing dynamic
interactions as it provides information about signal-average buoyant molar mass (87).
Sedimentation equilibrium is an absolute technique for molecular weight measurement;
since the shape of the macromolecule does not affect the measurement.

When

sedimentation equilibrium (by collaborators Swairjo Group) analysis was carried out on
QueF, it was observed to migrate with an apparent Mr of 182 kDa, lower than the
theoretical Mr of the decamer (194 kDa), suggesting the presence of smaller multimeric
species. When fitting the data assuming two multimeric species in equilibrium, pentamer
and decamer, the apparent Kd for the pentamer-decamer equilibrium was calculated to be
140-240 nM. There was no indication of a higher molecular weight aggregate for the
native protein. The QueF-*PreQ0 complex ran with an apparent average Mr 189 kDa,
indicating a shift in equilibrium toward the decamer. The apparent Kd for decamer
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formation is 35-37 nM, lower than that of the QueF enzyme alone, indicating a substrateinduced tightening or stabilization of the decamer.

In transient kinetics when the kinetics of substrate binding is very fast, the observed
kinetics are a reflection of the rate of catalysis at the active site (88). Stopped-flow
methods are typically applied when there is an observable signal, the most commonly
used being absorbance or fluorescence. These two signals are limited mainly by the fact
that the concentration of the substrates is dictated by the extinction coefficients and
quantum yields (89), but averaging of several reaction traces significantly increases the
ratio of signal to noise (S/N). Fluorescence has the disadvantage that it is difficult to
obtain stoichiometric amplitude data.

Proteins exhibit intrinsic fluorescence due to the presence of phenylalanine, tyrosine and
tryptophan. QueF sequence analysis revealed that it only contains one tryptophan residue
and the crystal structure revealed that the tryptophan residue was ~ 20 Å from the active
site cysteine residue. Therefore, any change in the tryptophan fluorescence would be a
reflection of structural changes occurring in the protein and not due to tryptophan directly
interacting with the preQ0. Tryptophan is particularly useful as it is very sensitive to its
immediate environment and can be used in monitoring conformational changes, subunit
associations, and substrate binding, as these processes can be accompanied by changes in
its emission spectra (90). Tryptophan fluorescence can be selectively excited at 295 305 nm (90), in all the tryptophan fluorescence assays for substrate binding tryptophan
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was excited at 295 nm. Analysis of the microenvironment (4 Å) of the tryptophan
residues in two subunits (in the presence and absence of preQ0) revealed two major
differences (Figure 58); first an aspartic acid residue is present in very close proximity to
the tryptophan residue in the subunit without preQ0 but not in the subunit with preQ0.
Second, methionine and lysine residues are present close to the tryptophan in the subunit
with preQ0 bound to it but not in the subunit without preQ0. The emission spectra of
QueF in the presence and absence of preQ0 were obtained, and quenching of the
tryptophan fluorescence was observed in the presence of preQ0 as well as a shift in the
emission maxima, consistent with the changes in the QueF structure upon preQ0 binding.

In the wild type QueF a covalent intermediate is formed. In order to investigate whether
the quenching observed was due to thioimide formation or preQ0 binding, fluorescence
measurements were made with the C55A mutant. The fluorescence of C55A, which
lacks the cysteine residue required for the formation of the thioimide, was shown to be
reduced in the presence of preQ0, supporting the hypothesis that the binding of preQ0 to
QueF is accompanied by conformational changes in the protein. Stopped flow analysis of
tryptophan fluorescence indicated that the fluorescence change in the wild type QueF was
biphasic while the change in the C55A mutant was monophasic. The biphasic profile
suggested that the observed fluorescence quenching was due to at least two events
occurring upon the mixing of QueF with preQ0. Non-linear regression analysis of the
fluorescence data from the experiments carried out with wild type and mutant showed
that the fast phase in the binding of preQ0 to the wild type gave a comparable rate to the
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calculated rate of preQ0 binding observed in the C55A mutant (1.32 µM-1s-1 and 1.06 µM1 -1

s respectively).

Stoppped flow kinetic analysis was also determined for thioimide formation.
Interestingly, the rate of thioimide formation (2.55 s-1 at 30 °C) was observed to be
similar to the value determined for the slow phase in tryptophan quenching (1.3 s-1 at 20
°C), indicating that the further quenching observed in the wild type protein and not in the
C55A mutant was due to thioimide formation. The preQ0 binding experiments monitored
by tryptophan fluorescence were determined at 20 °C instead of 30 °C because the fast
phase of the preQ0 binding was almost completely absent from the experiments
determined at 30 °C, such that the quenching observed was mainly due to thioimide
formation. No significant differences in the crystal structures of the QueF with preQ0
bound and the one with the thioimide formed were observed, suggesting that no
additional structural changes take place as a consequence of thioimide formation.
Therefore, the slow second phase in the tryptophan fluorescence is formation of the
thioimide, that locks the protein in the QueF-*PreQ0 conformation thereby the shifting
the equilibrium towards the QueF.PreQ0 binary complex. The equilibrium between the
free QueF and QueF.PreQ0 complex, which is apparent within a few milliseconds of
mixing preQ0 with the C55A mutant, is therefore not reached immediately due to the
thioimide formation.
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Thioimide formation was directly followed by absorbance at 370 nm. Fitting a simple
two step mechanism to the thioimide formation resulted in residuals that were nonrandom from a global analysis of the data (Figure 44C), suggesting that the mechanism of
thioimide formation was more complex. Given our knowledge of the presence of a preexisting equilibrium between the pentamer and decamer states of the protein, a step
indicating such an equilibrium was added to the mechanism and this dramatically
improved the residuals, suggesting that the pre-existing equilibrium between the different
states of the protein might influence the kinetics observed. The need for a pre-existing
equilibrium in fitting the thioimide data was unexpected as this was not necessary when
preQ0 binding data was analyzed. It is also possible that more than one form of QueF is
able to form the thioimide, although we have is no direct evidence that addresses this
issue.

Thioimide formation under single turnover conditions was shown to fit well to a single
exponential equation in analyses using Kaleidagraph.

However, when the preQ0

concentration was greater than the QueF concentration a second exponential rate was
observed. Examples of this are shown in Figures 44D - F. The appearance of a second
rate was not expected. The fast phase observed under single turnover conditions could be
due to the reaction occurring between QueF in a more reactive conformation. In theory,
preQ0 could bind to either the pentamer or decamer states. Given the more open nature
of the pentamer, the reaction might occur more readily in this state than in the decamer.
It is clear though that the binding of preQ0 shifts the equilibrium to the decamer state.
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The presence of a small population of monomer QueF-*PreQ0 observed in the gel
filtration analysis might also be an explanation for the second rate observed in thioimide
formation. There might be a fraction of the population that is still able to react with the
preQ0 but is slower than the predominant form. Though it seems unlikely, a monomer
subunit of QueF might form the thioimide, when there is excess preQ0 in solution such
that the more reactive population has already reacted. This argument is consistent with
the observation that the thioimide formation is strictly monophasic at low preQ0
concentrations. The presence of the second rate might also be due to re-estabilishing the
equilibrium of the pentamer and decamer states of the protein accompanied by changes in
extinction coefficient such that an increase in absorbance is observed. The thioimide
formation was determined on two different instruments in order to check if the residual
pattern was an artifact due to the instrument. However the same residual pattern was
observed, suggesting that the observation of the non-random residuals was not due to the
stopped flow instrument drifting but a characteristic of the reaction being observed.

The kinetics of NADPH binding were determined by following the fluorescence of
NADPH, which is quenched upon binding to protein.

Association and dissociation

constants of NADPH to the E78A-*PreQ0 complex were determined under pseudo-first
order conditions. The QueF mutant was used in order to look at the binding kinetics
completely separate from NADPH oxidation.

The kinetics observed were biphasic.

Initial attempts to fit the data to a single exponential decay resulted in poor fitting, while
fitting with a double exponential decay produced a better fit. We propose that the fast
97

phase corresponds to the association and dissociation of the NADPH from the protein
complex, while the slow phase is due to either isomerization of the binary complex
(QueF-*PreQ0.NADPH) or it can also be an artifact of the E78A mutation since this
residue interacts directly with preQ0 and it is substituted with alanine which is unable to
make the same interactions. The biphasic change noted in this protein, which is unable to
reduce the thioimide in the active site, has been previously observed in other
dehydrogenases such as aldolase reductase (91), acetohydroxy acid isomeroreductase
(92), human aldolase reductase (93) where changes in conformation upon the binding of
NADPH have been suggested to also occur.

The rate of reduction of the thioimide was analyzed using both fluorescence and UV
absorption analysis. Direct monitoring of the loss of NADPH absorption at 340 nm, as
done previously in the steady state analysis of QueF (71), could not be used under single
turnover conditions because of the overlap of the thioimide peak with that of NADPH
(Figure 47). The kinetics of thioimide loss followed at 390 nm under single turnover
conditions fit well to a single exponential decay. The change in absorbance at 390 nm
was monophasic, an indication that the observed change was most likely due to a single
event taking place, in this case the reduction of the thioimide. When fluorescence of
NADPH was used as the reporter, the association and dissociation of NADPH was
observed as the fast phase. The value of association of NADPH with QueF-*PreQ0
complex was found to be 0.06 µM-1 s-1, which is less than that measured for E78A (0.2
µM-1 s-1). This might be due to differences in the size and polarity of the R-groups of the
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two residues. Even though E78 appears not to directly interact with the NADPH in the
crystal structure, having alanine in that position might make it more accessible for the
NADPH binding because of its smaller R-group even though the mutation results in an
inactive protein.

The data for the single turnover of NADPH was fit to a double

exponential decay, suggesting that under single turnover conditions there are at least two
events taking place, the binding of NADPH and its subsequent oxidation in the reduction
of the thioimide. This model was also supported by the data obtained from loss of the
thioimide absorbance observed at 390 nm under single turnover conditions. The rate for
the reduction of the thioimide was found to be comparable from both fluorescence and
UV data suggesting that the proposed two step model is possible where an enzyme
isomerization does not take place. The apparent absence of an isomerization step under
single turnover conditions might be either because it induces such a subtle change in the
protein complex that it makes it difficult to detect or that in the native protein the
isomerization step occurs so fast that it does not change the overall kinetics being
observed. The apparent isomerization in the E78A mutant might also be an artifact due
to the mutation.

Multiple turnover kinetics of QueF was analyzed. Proposing a model for the calculation
of rate constant was difficult. QueF-*PreQ0 was used in order to reduce the steps to be
determined; other constraints on the model included the experimentally measured value
for the first reduction of the thioimide, which was held constant, as well as the binding of
the second NADPH, which was assumed to be identical to the first NADPH. The
99

presence of a single NADPH site for two preQ0 sites, and two reduction cycles for each
preQ0 site, complicated the analysis. Some questions were difficult to answer, including
the following: are the two sites equivalent? Upon binding of the second equivalent of
NADPH, does the intermediate from the first reduction preferentially get reduced over
the thioimide or is this still random? Does the protein undergo structural changes in
order to accommodate the reduction of the intermediate? The affinity for the enzyme for
NADP+, which could affect its rate of diffusion, is also unknown at this point.

The data obtained for the multiple turnover experiment was complex (Figure 59) and it
was not possible to fit simple decay equations to the data obtained. In the presence of
low NADPH concentrations, the data could be fit to a double exponential decay.
However, as the concentration was increased, the shape of the plot changed. The data
was analyzed using Dynafit for a global fitting. The initial fast phase found in all the
traces was attributed to the binding of NADPH and its subsequent quenching. However
the almost constant fluorescence signal at higher NADPH concentrations might be due to
several factors, which include, but are not limited to, the following: after the initial
reduction of the thioimide, the NADP+ does not readily diffuse away, it might require a
conformational change to take place before it can diffuse or the binding of the second
equivalent of NADPH is accompanied by conformational changes. Alternatively the
apparent constant fluorescence at high NADPH concentrations might be due to the excess
NADPH which has a higher quantum yield than protein bound NADPH which is
associated with any of protein. Only the k2 and k5 were calculated from the multiple
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turnover data analysis and all other constants were determined by other experiments and
were held constant for the analysis.

The transient kinetic analysis results indicate that the binding of preQ0 and NADPH to
QueF, as well as thioimide formation are very rapid. Reduction of the thioimide and
imine intermediate are most likely the rate-limiting steps, and analysis of component
rates suggest that structural changes occur between these steps, further limiting the
overall rate. Structural analysis of QueF indicates that this protein exists in equilibrium
between the pentamer and decamer states. There is also evidence that there might be
small fraction of the protein which exits as a monomer which is in equilibrium with the
multimeric proteins. The addition of preQ0 or divalent metals results in stabilization of
the decamer structure. All the data combined is consistent with structural changes taking
place after addition of a substrate.
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4.3 QueA

Previous work carried out has shown that the formation of the C-N bond occurs at C4’,
which led to our proposed mechanism. Proton abstraction could occur by two possible
routes which are shown in Figure 12. The first mechanism shows that deprotonation
occurs prior to formation of the C-N bond while the second mechanism shows that the CN bond is formed first before the C5’ proton is removed, resulting in an SN2 mechanism.
Even though the SN2 mechanism is simpler, such a reaction at a secondary carbon is
highly unfavorable, and therefore the mechanism is more likely to occur by an
elimination/addition mechanism that makes use of the favorable pKa in the first step. In
the SN2 mechanism the known stereochemistry of the oQ limits this mechanism to only
procede with loss of the pro-R proton.

Elimination/addition mechanism is compatible with loss of either the proR or proS
hydrogen since the stereochemistry at C5’ is lost.

However, elimination/addition

mechanism requires syn or anti relationship between the proton removed and the C4’-O
bond. The conformation about the C4’-C5’ bond AdoMet indicates that the mechanism
would most likely favor loss of proS hydrogen.

During the transfer of the ribosyl group from AdoMet to form oQ, one of the hydrogens
at the C5’ position is lost. Elucidating the stereochemistry of this reaction is fundamental
to understanding the mechanism of QueA. To investigate the stereospecificity of QueA,
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stereospecifically labeled deuterated AdoMet was used to determine if the proton
abstraction was stereospecific. PreQ1-tRNA, which had been converted to oQ-tRNA, was
digested as previously described (63), and chromatograms showing the products of these
digestions are shown in Figure 51. oQ samples generated from 5’R-[5’D]-AdoMet, 5’S[5’D]-AdoMet and unlabeled AdoMet were all lyophilized and analyzed by mass
spectrometry. The results of these analyses are shown in Figure 52.

The results obtained from mass spectrometry analysis were consistent with an
elimination/addition mechanism in which the proS hydrogen is lost.

Loss of the

deuterium was shown in the oQ prepared using proS AdoMet, which resulted in a mass of
426 m/z the same as the one obtained when unlabeled AdoMet was used, while the oQ
prepared using proR AdoMet was 427 m/z, consistent with loss of the proS proton as the
deuterium label was retained in this sample (Figure 52). The results obtained support an
elimination/addition mechanism.
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Tables and Figures

Figure 1: The structures of the 7-deazaguanosine hypermodified nucleosides of transfer RNA.
Figure taken from (37).

Figure 2: Class 1 tRNA canonical structure.
(A) Nucleotides 15 and 48, forming the Levitt base pair. (B) Ribbon representation of the yeast tRNAPhe
structure. Figure taken from (24).
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Figure 3: Electron density difference in the base plane between [Mg(H2O)5G]2+ and the simple G
base.
(A) archaeosine (fa7d7G) (B) G base. Figure taken from (24)
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Figure 4: The biosynthetic pathway of the preQ0.
Figure taken from (45).

105

N
H

H2N

N

preQ0

N
H

Figure 5: The biosynthetic pathways of archaeosine and queuosine in archaea and bacteria.
Figure taken from (41).

Figure 6: QueF catalyzed reaction.
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Figure 7: Multimeric barrels by the T
T-folds for functionally different enzyme.
The monomer units are shown in color. (A) 66-Pyruvyltetrahydropterin
Pyruvyltetrahydropterin synthase (PTPS) (hexamer).
(hexamer) (B)
Urate oxidase (UOX)
X) (tetramer)
(tetramer). (C) Dihydroneopterin aldolase (DHNA) (octamer). (D) GTP cyclohydrolcyclohydrol
ase I (GCYH I) (decamer). The enzymes are composed of barrels superposed face to face.
face Figure taken
from (57).

Figure 8: Different pathways of nitrile metabolism.
Figure adapted from (58)
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Figure 9: Proposed kinetic scheme of QueF based on the Bi-Uni-Uni Ter-Ter Ping Pong kinetic
mechanism
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Figure 10: QueA catalyzed reaction.
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Figure 11: QueA follows an ordered Bi - Ter mechanism.
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Figure 12: Possible Mechanisms of the QueA Reaction Consistent with C-N bond formation at C4’.
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Figure 14: PreQ0 semi-preparative HPLC purification.
PreQ0 was purified on a semi-preparative Luna C18 column (250 x 10 mm, 5 µm) from Phenomenex. The
preQ0 eluted in a 20 minute run, eluting at 12.5 minutes under gradient conditions; 96% 25 mM NH4OAc
(pH 6.0)/4% methanol for 10 minutes followed by a gradient of 96% 25 mM NH4OAc/4% methanol up to
85% 25 mM NH4OAc/15% methanol over 10 minutes at a flow rate of 4 mL/min .

Figure 15: Schematic of a stopped flow instrument.
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Figure 16: Analysis of the TgtA and TgtA2 families.
A) Predicted role of TgtA2 in archaeosine biosynthesis. B) Clustering of tgtA and tgtA2 genes in Archaea.
C) Shared modular structure of TGT and TgtA2 proteins. Only the long (full-length) forms are shown. The
active site and known catalytic residues of TGT (P. horikoshii numbers) and the conserved TgtA2 motif
(M. jannaschii numbers) in the presumably catalytic C1 domain (starred) of TgtA2 are shown. The zincbinding residues are found in all but six TGTs and in ∼60% of the TgtA2 sequences analyzed. Figure taken
from (70)
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Figure 17: SDS-PAGE
PAGE analyses of MjTgtA2 purification.
lane 1, MW marker;; lane 2, cell lysis free extract; lane 3, CFE after heating at 60 ºC; lane 4, CFE after
heating a 75 ºC; lane 5, Trx-his
his6-MjTgtA2; lane 6, Self cleaved MjTgtA2; lane 7 purified C-terminal
C
his6MjTgtA2
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A)

B)
MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLTVAKLNIDQNPG
TAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLAGSGSGH
TAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLAGSGSGHMHHHHHHSSGLVPRGS
HHHHHHSSGLVPRGS
GMKETAAAKFERQHMDSPDLG
DSPDLGTGGGSGIEGR
C)
MLEPIAYDIGRLCKEEDKELTPKLIDIDVIGLSQEKIFYGIMTPFRCPNSKSIYELRKSYVKADGIKMP
FDTFRELTSIFKKSFIGTVKYKGNVFKYQILNFGKHVDLIELEDADLYIIADGRRLIERKELQIIPKIR
TVKYKGNVFKYQILNFGKHVDLIELEDADLYIIADGRRLIERKELQIIPKIR
EKISPNSAIYSPAVFPWEIPLLAYIGVDYFDDSLAKLYASMGYKFTKNRAVKVDSFSFEELYNNNK
KVYEEILEEVRIAIKNGFLRNVVEETAVSHPYLWANYRRYEPDLRNIPLSKE
KVYEEILEEVRIAIKNGFLRNVVEETAVSHPYLWANYRRYEPDLRNIPLSKENKIIVTTNINIPEVKK
NKIIVTTNINIPEVKK
YLERLDNYEPYSNIIVLLPCSSKKPYSISQSHQKFIKAIKSAKVVVEEVILTSPYGLVPRALERLVNY
DIPVTGEWSFEEIELINNCLKNFLKKVKEKFDDYIVIAHLPEHYLEILELDDIVITSKGNPTSEEALKN
LTDTLKKYKELTKSKDINKKGQRIHNIQQLAEFQFGINFIPNEIFINHKGQIFTKINNKNQQIASINPK
NGLLILTLSGGELLWNSGGKDINYIEVNYEIKKG
NGLLILTLSGGELLWNSGGKDINYIEVNYEIKKGSLFPPGFVDCNENISYNDEVVLIKDDTFLGIGR
SLFPPGFVDCNENISYNDEVVLIKDDTFLGIGR
ALMSGFEMKKAKHGALVNIRNVKS
Figure 18: Edman degradation of MjTgtA2 bands.
(A) SDS-PAGE
E indicating the bands sequenced by Edman degradation, lane 1, Trx-his
his6- MjTgtA2; lane 2,
Self cleaved MjTgtA2;; lane 33, purified C-terminal his6- MjTgtA2. (B) Thioredoxin Fusion tag sequence
(from the pET32/Xa LIC vector) indicating the site of proteolysis in bold and underlined. (C) MjTgtA2
native sequence indicating the site of proteolysis in bold and underlined, the ita
italics
lics indicate the other site of
proteolysis.
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Figure 19: HPLC gel filtration analysis of Thioredoxin-His6 MjTgtA2 and cleaved MjTgtA2.
MjTgtA2 (discontinuous line) elutes at 8.75 minutes and cleaved MjTgtA2 (continuous line) elutes at 8.88
minutes. Inset: standard curve presented as log MW vs. KD. The standards used in the calibration included;
Carbonic Anhydrase (29KDa), BSA (66 KDa), Alcohol Dehydrogenase (150 KDa), β-Amylase (200 KDa),
Apoferritin (443 KDa) and Thyroglobulin (669 KDa). Each data point represents the average of 2 trials.
The protein standard data fit the linear regression y =4.111- 3.245 x (R=0.967). Determined Molecular
mass of Thioredoxin- His6 MjTgtA2 was 154 KDa (Calculated for dimer 155 kDa). Determined molecular
mass of cleaved MjTgtA2 122 KDa (Calculated for cleaved dimer 114 kDa).

Figure 20: Purification of tRNASer from prep cell.
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activity
Figure 21: Glutaminase activity of MjTgtA2 coupled with glutamate dehydrogenase activity.
NADPH formation was monitored at 340 nm. 30 and 60 µg of protein were used, in a solution containing
50 mM phosphate (pH 7.5), 0.5 M NaCl, 20 µM preQ0-tRNASer, 15 mM MgCl2, 1 mM DTT, 2.5 mM Gln,
1 mM NADP+ and 4 U of glutamate dehydrogenase at 37 ºC.

Figure 22:: Glutaminase activity as a function of increasing concentration of MjTgtA2
TgtA2.
Reaction conditions; 100 mM HEPES (pH 7.0), MjTgtA2 (MJ1022) (2.0 – 20 µg). 0.5 M NaCl, 15 mM
MgCl2, 2 mM DTT, 12.4 µM [(U)
[(U)-14C]-L-Gln, 20 µM preQ0-tRNASer
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Figure 23: Temperature profile determination of MjTgtA2.
Reaction conditions; 100 mM HEPES (pH 7.0), 0.5 M NaCl, 20 mM MgCl2, 1 mM DTT, 10 µM [(U)-14C]Gln and 20 µM preQ0-tRNASer, 7.8 µg MjTgtA2

Figure 24: pH profile determination of MjTgtA2.
Reaction conditions; 100 mM Tris/Mes/Acetate, 0.5 M NaCL, 20 mM MgCl2, 1 mM DTT, 10 µM [(U)C]-Gln and 20 µM preQ0-tRNASer, 7.8 µg MjTgtA2.

14
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Figure 25: Activity of MjTgtA2 in different buffers.
Reaction conditions; 100 mM buffer, 0.5 M NaCl, 20 mM MgCl2, 1 mM DTT, 10 µM [(U)-14C]-Gln and
20 µM preQ0-tRNASer, 7.8µg MjTgtA2

Figure 26: Asparaginase activity of MjTgtA2.
Reaction conditions; 100 mM HEPES (pH 7.0), MjTgtA2, 0.5 M NaCl, 15 mM MgCl2, 2 mM DTT, 12.4
µM [3H]-L-Asn, 20 µM preQ0-tRNASer
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Figure 27: HPLC analysis of tRNA nucleosides from MjTgtA2 activity.
Amidotransferase activity was determined in the presence of NH4Cl, Gln or Asn at 40 ºC. The tRNA was
purified and digested as previously stated and analyzed on HPLC. (A) Reversed phase HPLC separation of
nucleosides from preQ0-tRNASer (red) and G+-tRNASer (blue). (B) PreQ0 characteristic chromophore. (C)
Archaeosine characteristic chromophore.
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Figure 28:: ESI mass spectrum of nucleosides archaeosine and preQ0 nucleoside
(A) G+ Mr calculated, 324, MH+ ion 325, Mr of the neutral base of G+ 192, BH2+ ion 193. (B) PreQ0
calculated mass 307, MH+ ion 308.
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Figure 29: SDS/PAGE analyses of QueF purification by Ni2+-NTA agarose chromatography.
chromatography
lane 1 , MW marker ; lane 2 , cell lysis free extract
extract; lane 3, flow through; lane 4, wash ; lane 5, purified
His6-QueF.

Figure 30:: SDS/PAGE analyses of cleaved QueF proteins.
lane 1, MW marker ; lane 2, Wild type QueF; lane 3, C55A mutant; lane 4, E78A mutant
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activity.
Figure 31:: Effect of Divalent metals on native QueF activity
Reaction conditions: 100 mM Tris
Tris-HCl
HCl (pH 7.5), 100 mM KCl, 1 mM DTT, 80 µM NADPH, 150 µM
preQ0, 1 µM QueF, and the divalent metal (0 to 10 mM) at 30 ºC. The change in absorbance of NADPH
was monitored at 340 nm.
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Figure 32: Effect of Divalent metals on demetallated QueF activity.
Reaction conditions: 100 mM Tris-HCl (pH 7.5), 100 mM KCl, 1 mM DTT, 80 µM NADPH, 150 µM
preQ0, 1 µM QueF, and the divalent metal (0 to 10 mM) at 30 ºC. The change in absorbance of NADPH
was monitored at 340 nm.

123

A.

B.

Figure 33: Effect of KCl concentration on QueF activity.
A) Native QueF B) Apoprotein 1) 100 mM KCl 2) 50 mM KCl 3) 10 mM KCl 4) 100 mM KCl and 0.25
mM MnCl2 5) 50 mM KCl and 0.25 mM MnCl2 6) 10 mM KCl and 0.25 mM MnCl2. Assay conditions;
100 mM Tris-HCl, 1 mM DTT, 80 µM β-NADPH, 150 µM preQ0, 1 µM QueF and KCl varied.
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Figure 34: pH profile determination of QueF
Assay conditions: 100 mM Buffer, 50 mM KCl 1 mM DTT, 80 µM β-NADPH, 100 µM preQ0, 2 µM
QueF, and 250 µM MnCl2 reaction was carried out at 30 °C
(A) MES (pH 5.75 - 6.55) and Tris-HCl (pH 7.0 - 8.0) (B) potassium phosphate
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A.

B.

Figure 35: HPLC analytical gel filtration analysis of QueF.
(A) QueF alone elutes at 8.57 min (B) QueF alone in the presence of 0.5 M KCl and 10 mM EDTA elutes
at 8.78 min and at 10.4 min.
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A.

.
C.

Figure 36: HPLC analytical gel filtration analysis of QueF-PreQ0 complex.
(A) QueF-PreQ0 complex elutes at 8.33 min (B) Spectrum at 8.33 min i.e decamer (C) Spectrum at 10.4
min (monomer).
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Homodecamer.
Figure 37: B. subtilis QueF Homodecamer
One subunit is highlighted in red. Mg2+ ions are shown as magenta spheres. Bound preQ0 molecules are
shown in cyan. Bound glucose sulfate or glucosamine found in the non
non-covalent
covalent complex is shown in
green in the NADPH binding pocket.

Figure 38:: Crystal structure of QueF pentamer.
One subunit is highlighted in blue, the thioimide is shown in red.
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Figure 39: Thioimide formed in the active site of QueF
QueF.

Figure 40: QueF Cofactor Binding site
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A.

B.

Figure 41: QueF and NADPH Fluorescence.
Excitation of QueF at 295 nm and of NADPH at 340 nm is shown. (A) 50 mM phosphate (pH 6.5), 50 mM
KCl, 1 mM DTT, 250 µM MnCl2, 80 µM QueF and 100 µM preQ0 (the solid line) and without preQ0
(broken line). (B) NADPH fluorescence.
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B.

Figure 42: Transient state analysis of tryptophan quenching upon preQ0 binding to C55A.
(A) Global analysis of preQ0 binding (final concentrations in reaction: 200 µM QueF, 50 mM potassium
phosphate (pH 6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT and preQ0 (6.8, 11.8, 18.2, 23.3, 29.2, 38.8,
50.0 µM). The reaction was carried out at 20 °C. (B) residuals for the fit at 38.8 µM preQ0. Time is in
seconds.
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A.

B.

Figure 43: Transient state analysis of tryptophan quenching upon preQ0 binding to wild type QueF.
(A) Global analysis of preQ0 binding (final concentrations in reaction: 200 µM QueF, 50 mM potassium
phosphate (pH 6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT and preQ0 (5.3, 15.4, 22.6, 30.4 µM). The
reaction was carried out at 20 °C. (B) residuals for the fit at 15.4 µM preQ0. Time is in seconds.
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B.

D.

F.

ransient state
Figure 44: Absorbance measurements of thioimide formation in QueF under transient
conditions.
(A) Global analysis of thioimide formation (final concentrations in reaction: 62 µM QueF, 50 mM
potassium phosphate (pH
pH 6.5
6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT and preQ0 concentration was
varied (shown in figure). (B) R
Residuals for the fit in the presence of an isomerization
n step.
step (C) Residuals
obtained in the absence of isomerization
isomerization. (D) Thioimide formation at low preQ0 concentrations (40 µM
QueF and 7.8 µM preQ0). (F) Single exponential fit for thioimide formation at high preQ0 concentrations
(40 µM QueF and 400 µM preQ0). (F) Double exponential fit for thioimide formation at high preQ0
concentrations (40
40 µM QueF and 400 µM preQ0).
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Figure 45: Transient state analysis of NADPH binding to E78A
(A) Single exponential decay fit for NADPH binding (100 µM E78A-*PreQ0 and 69.28 µM NADPH). (B)
Double exponential decay fit for NADPH binding (100 µM E78A-*PreQ0 and 69.28 µM NADPH). (C)
Global analysis of NADPH binding to E78A-*PreQ0. (C) Residuals for the global fit analysis. The
reaction was carried out at 20 ºC in 50 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 µM
MnCl2, and 1 mM DTT. The E78A QueF mutant (200 µM) was incubated with 700 µM preQ0 for 10
minutes before mixing with varying concentrations of NADPH. The final concentrations of NADPH in the
assay were; 16, 23.5, 31.8, 39.4, 50.3, 57.44, and 69.28 µM. The final concentration of E78A-*PreQ0 in
the reaction mixture was 100 µM.
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Figure 46: Transient state analysis of NADPH fluorescence
(A) Global analysis of NADPH binding to QueF-*PreQ0. (B) Residuals for the global fit analysis. The
reaction was carried out at 20 ºC, 50 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 µM
MnCl2, and 1 mM DTT. The final concentrations of NADPH in the assay were 8; 16, 23.5 µM and QueF*PreQ0 was 72.5 µM.
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Figure 47: Thioimide and NADPH spectra

20 µM

26.3 µM

Figure 48: Transient state analysis of thioimide loss 390 nm.
The reaction was carried out at 30 ºC in 50 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 µM
MnCl2, and 1 mM DTT, with final concentrations of QueF-*PreQ0 at 180 µM in the presence of 20 and
26.3 µM NADPH.
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Figure 49: Thioimide decomposition.
Thioimide decomposition was monitored at 370 nm at 30 ºC, in the presence of 50 mM potassium
phosphate buffer (pH 6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT, ~ 154, 158 and 161 µM QueF*PreQ0.

Figure 50: SDS/PAGE analyses of QueA purification.
MW marker ; lane 1 , Cell free extract; land 2 , flow through; lane 3, wash 1; lane 4 wash 2; lane 5, wash
3 , lane 6, purified His6-QueA.

137

Figure 51: LC analysis of tRNAtyr hydrolysates before and after QueA catalysis

A

B

m/z

C

m/z

m/z

Figure 52: Mass spectrometry analysis of the oQ generated from QueA reactions
(A) Unlabelled AdoMet (B) 5’S-[5-D]-AdoMet (C) 5’ R-[5-D]-AdoMet
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Figure 53: AdoMet NMR analysis.
(A) AdoMet showing the stereospecificity of the C5' hydrogens (B) Proton NMR of the AdoMet used in
the determination of stereospecific abstraction by QueA. The proR proton is at the chemical shift of δ 4.05
in the unlabeled AdoMet while the proS proton is at the chemical shift of δ 3.919.
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Figure 54:: Possible routes for the formation of G+.

Figure 55: Alignment of unimodular FolE (GTP cyclohydrolase I) and YkvM (QueF) sequences.
The conserved Cys and Glu found in the substrate binding pocket of both protein families are indicated by
asterisks. The QueF motif, specific for the QueF family, is highlighted in green. The zinc binding His and
Cys residues found in FolE and not in QueF are highlighted in blue. Other catalytic residues in FolE not
found in QueF are highlighted in yellow. The absence of the zinc
zinc-binding
binding and catalytic residues of FolE is
the best identifier of QueF sequences in genome databases. Taken from reference (47)
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Figure 56: Three-dimensional model B. subtilis QueF.
Putative active site of B. subtilis QueF based on the homology model built from the crystal structure of E.
coli GTP-CH-I. The active site is located at the interface between two monomers shown in light and dark
grey. Potential active-site interactions are indicated. The conserved QueF motif region is highlighted in
green. The conserved Glu characteristic of T-fold enzymes and the invariant Cys shared between QueF and
GTP-CH-I are shown in black.

Figure 57: Proposed chemical mechanism for the QueF catalyzed reaction.
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Figure 58:: Partial structure of QueF with bound preQ0 showing the electrostatics around the
tryptophan residue in the presence and absence of preQ0
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Figure 59:: NADPH quenching in a reaction with QueF-*PreQ0 under mutiple turnover conditions.
conditions
Proposed mechanism for the observed reaction shown below (summary of the determined rates is shown in
table 4).

[mechanism]
E-S + NADPH

.

E-S NADPH

.

ES NADP+
ES + NADPH

.
FS.NADPH

ES NADPH

.
ES.NADP

E-S NADPH
+

: kas kds
: k1

ES + NADP+

.
FS.NADPH
F.P.NADP

ES NADPH

: k2
: k3 k-3
: k4 k-4

+

: k5
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Table 1 : Edman Degradation results.
Bands correspond to the bands in Figure 18A.
N-terminal sequences
Band Name
A

HMDSPD; DSPDLG

B

ELTSI

C

IFKKSF, KKSFIG ( minor SIFKKS)

D

SIFKK

Table 2 : G+ formation as function of pH
pH
5
6
7
8
8.5

G+
Absent
Absent
Present
Present
Present

Table 3 : Calculated rate constants for E78A-PreQ0 binding NADPH at 20 °C
Constant

Value

kas
kds
k1
k-1

0.20 µM-1s-1
0.24 s-1
1.18 s-1
0.12 s-1

Table 4: Calculated rate constants for wild type QueF for NADPH binding and catalysis at 20 °C
(NADPH fluorescence)
Constant
kas
kds
k1
k2
k3
k-3
k4
k-4
k5

Value
0.06 µM-1s-1
0.20 s-1
0.12 s-1
0.067 s-1
0.060 µM-1s-1
0.20 s-1
1.2 s-1
0.053 s-1
0.12 s-1
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Table 5: Calculated rate constants for wild type QueF for preQ0 binding and catalysis 20 °C
(tryptophan fluorescence)
Constant
kas
kds

Value
1.32 µM-1s-1
7.95 s-1

kr (thiomide formation)

1.30 s-1

Table 6: Calculated rate constants for C55A QueF for preQ0 binding 20 °C (tryptophan
fluorescence)
Constant
kas
kds

Value
1.06 µM-1s-1
1.35 s-1

Table 7: Other rates determined by UV absorbance determined at 30 °C
Constant
Thoimide formation (370 nm)
Thioimide reduction (390 nm)

Value
2.55 s-1
0.24 s-1

Thiomide decomposition (370 nm)

4.81 x 10-6 s-1
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